<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article article-type="research-article" dtd-version="1.2" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">76804</article-id><article-id pub-id-type="doi">10.7554/eLife.76804</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-267647"><name><surname>Serrero</surname><given-names>Manutea C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8221-2725</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267648"><name><surname>Girault</surname><given-names>Virginie</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267745"><name><surname>Weigang</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267650"><name><surname>Greco</surname><given-names>Todd M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267651"><name><surname>Ramos-Nascimento</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-267652"><name><surname>Anderson</surname><given-names>Fenja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267653"><name><surname>Piras</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267654"><name><surname>Hickford Martinez</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267655"><name><surname>Hertzog</surname><given-names>Jonny</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7089-982X</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267656"><name><surname>Binz</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267657"><name><surname>Pohlmann</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267658"><name><surname>Prank</surname><given-names>Ute</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267659"><name><surname>Rehwinkel</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-267660"><name><surname>Bauerfeind</surname><given-names>Rudolf</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-18938"><name><surname>Cristea</surname><given-names>Ileana M</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-97403"><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0166-1367</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund8"/><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-96439"><name><surname>Kochs</surname><given-names>Georg</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund10"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-100460"><name><surname>Sodeik</surname><given-names>Beate</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4650-3036</contrib-id><email>sodeik.beate@mh-hannover.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund11"/><xref ref-type="other" rid="fund15"/><xref ref-type="other" rid="fund14"/><xref ref-type="other" rid="fund12"/><xref ref-type="other" rid="fund13"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2yqf98</institution-id><institution>Institute of Virology, Hannover Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2yqf98</institution-id><institution>RESIST - Cluster of Excellence, Hannover Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02kkvpp62</institution-id><institution>Institute of Virology, Technical University Munich</institution></institution-wrap><addr-line><named-content content-type="city">Munich</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0245cg223</institution-id><institution>Institute of Virology, Freiburg University Medical Center, University of Freiburg</institution></institution-wrap><addr-line><named-content content-type="city">Freiburg</named-content></addr-line><country>Germany</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00hx57361</institution-id><institution>Department of Molecular Biology, Princeton University</institution></institution-wrap><addr-line><named-content content-type="city">Princeton</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q496a73</institution-id><institution>MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/028s4q594</institution-id><institution>German Center for Infection Research (DZIF), Hannover-Braunschweig Partner Site</institution></institution-wrap><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00f2yqf98</institution-id><institution>Research Core Unit Laser Microscopy, Hannover Medical School</institution></institution-wrap><addr-line><named-content content-type="city">Hannover</named-content></addr-line><country>Germany</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/028s4q594</institution-id><institution>German Center for Infection Research (DZIF), Munich Partner site</institution></institution-wrap><addr-line><named-content content-type="city">Munich</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Geballe</surname><given-names>Adam P</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ojala</surname><given-names>Päivi M</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/040af2s02</institution-id><institution>University of Helsinki</institution></institution-wrap><country>Finland</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>27</day><month>04</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e76804</elocation-id><history><date date-type="received" iso-8601-date="2022-01-05"><day>05</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-04-22"><day>22</day><month>04</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-01-27"><day>27</day><month>01</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.01.25.477704"/></event></pub-history><permissions><copyright-statement>© 2022, Serrero et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Serrero et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-76804-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-76804-figures-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="commentary" xlink:href="10.7554/eLife.79813"/><abstract><p>Host proteins sense viral products and induce defence mechanisms, particularly in immune cells. Using cell-free assays and quantitative mass spectrometry, we determined the interactome of capsid-host protein complexes of herpes simplex virus and identified the large dynamin-like GTPase myxovirus resistance protein B (MxB) as an interferon-inducible protein interacting with capsids. Electron microscopy analyses showed that cytosols containing MxB had the remarkable capability to disassemble the icosahedral capsids of herpes simplex viruses and varicella zoster virus into flat sheets of connected triangular faces. In contrast, capsids remained intact in cytosols with MxB mutants unable to hydrolyse GTP or to dimerize. Our data suggest that MxB senses herpesviral capsids, mediates their disassembly, and thereby restricts the efficiency of nuclear targeting of incoming capsids and/or the assembly of progeny capsids. The resulting premature release of viral genomes from capsids may enhance the activation of DNA sensors, and thereby amplify the innate immune responses.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>MxB</kwd><kwd>herpes simplex virus</kwd><kwd>interferon</kwd><kwd>GTPase</kwd><kwd>capsid</kwd><kwd>Mx2</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010661</institution-id><institution>Horizon 2020 Framework Programme</institution></institution-wrap></funding-source><award-id>H2020-EU.1.3.1</award-id><principal-award-recipient><name><surname>Rehwinkel</surname><given-names>Jan</given-names></name><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name><name><surname>Sodeik</surname><given-names>Beate</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00008/8</award-id><principal-award-recipient><name><surname>Rehwinkel</surname><given-names>Jan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NIGMS, GM114141</award-id><principal-award-recipient><name><surname>Cristea</surname><given-names>Ileana M</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>ERC-CoG ProDAP 817798</award-id><principal-award-recipient><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>PI1084/3</award-id><principal-award-recipient><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>PI1084/4</award-id><principal-award-recipient><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>PI1084/5</award-id><principal-award-recipient><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>TRR179/TP11</award-id><principal-award-recipient><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>TRR237/A07</award-id><principal-award-recipient><name><surname>Pichlmair</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>KO1579/13-1</award-id><principal-award-recipient><name><surname>Kochs</surname><given-names>Georg</given-names></name></principal-award-recipient></award-group><award-group id="fund11"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>CRC900 C2, 158989968</award-id><principal-award-recipient><name><surname>Sodeik</surname><given-names>Beate</given-names></name></principal-award-recipient></award-group><award-group id="fund12"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>EXC62 REBIRTH, 24102914</award-id><principal-award-recipient><name><surname>Sodeik</surname><given-names>Beate</given-names></name></principal-award-recipient></award-group><award-group id="fund13"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>EXC2155 RESIST, 390874280</award-id><principal-award-recipient><name><surname>Sodeik</surname><given-names>Beate</given-names></name></principal-award-recipient></award-group><award-group id="fund14"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SO403/6, 443889136</award-id><principal-award-recipient><name><surname>Sodeik</surname><given-names>Beate</given-names></name></principal-award-recipient></award-group><award-group id="fund15"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009139</institution-id><institution>Deutsches Zentrum für Infektionsforschung</institution></institution-wrap></funding-source><award-id>TTU 07.826_00</award-id><principal-award-recipient><name><surname>Sodeik</surname><given-names>Beate</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Novel cell-free biochemical experiments show that the host GTPase MxB can restrict the infection of alphaherpesviruses by disassembling the sturdy viral capsids so that they can no longer protect the viral genomes.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Infections with human alphaherpesviruses are associated with painful and stigmatizing manifestations such as herpes labialis or herpes genitalis, but also cause life-threatening meningitis or encephalitis, potentially blinding eye infections, herpes zoster, and post-herpetic neuralgia, particularly in immunocompromised patients (<xref ref-type="bibr" rid="bib35">Gershon et al., 2015</xref>; <xref ref-type="bibr" rid="bib98">Whitley and Roizman, 2016</xref>; <xref ref-type="bibr" rid="bib99">Whitley and Johnston, 2021</xref>). Herpes simplex viruses (HSV-1, HSV-2) and varicella zoster virus (VZV) productively infect epithelial and fibroblast cells of the skin and mucous membranes as well as neurons, but are restricted in immune cells. Macrophages, Langerhans cells, dendritic cells, and NK cells mount potent immune responses against alphaherpesviruses (<xref ref-type="bibr" rid="bib98">Whitley and Roizman, 2016</xref>).</p><p>Intracellular DNA sensors are crucial to sense herpesvirus infections, and to induce caspase-1-mediated inflammation and type I IFN expression (<xref ref-type="bibr" rid="bib41">Hertzog and Rehwinkel, 2020</xref>; <xref ref-type="bibr" rid="bib57">Kurt-Jones et al., 2017</xref>; <xref ref-type="bibr" rid="bib62">Lum and Cristea, 2021</xref>; <xref ref-type="bibr" rid="bib63">Ma et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Paludan et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Stempel et al., 2019</xref>). During an unperturbed infection, capsid shells shield herpesviral genomes from cytosolic sensors during nuclear targeting as well as after nuclear genome packaging (<xref ref-type="bibr" rid="bib3">Arvin and Abendroth, 2021</xref>; <xref ref-type="bibr" rid="bib28">Döhner et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Knipe et al., 2021</xref>). HSV-1 capsids can withstand compressive forces of up to 6 nN which is more than sufficient to endure the 18 atm repulsive pressure of the packaged viral DNA (<xref ref-type="bibr" rid="bib5">Bauer et al., 2013</xref>; <xref ref-type="bibr" rid="bib77">Roos et al., 2009</xref>). So far, it is unclear how cytosolic DNA sensors gain access to herpesviral genomes; either cytosolic host factors disassemble the sturdy herpesviral capsids during infection, or the nuclear envelopes become leaky.</p><p>HSV-1 virions contain an amorphous tegument layer that links the icosahedral capsids with a diameter of 125 nm to the viral envelope proteins (<xref ref-type="bibr" rid="bib23">Crump, 2018</xref>; <xref ref-type="bibr" rid="bib24">Dai and Zhou, 2018</xref>; <xref ref-type="bibr" rid="bib25">Diefenbach, 2015</xref>). To identify cytosolic proteins that promote or restrict infection by interacting with HSV-1 capsids, we have developed cell-free methods to reconstitute capsid-host protein complexes using tegumented capsids from extracellular viral particles or tegument-free capsids from the nuclei of infected cells (<xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>). Intact capsids are incubated with cytosol prepared from tissues or cultured cells, and the capsid-host protein complexes are isolated, and characterized by mass spectrometry (MS), immunoblot, electron microscopy, and functional assays. We could show that HSV-1 capsids require inner tegument proteins to recruit microtubule motors, to move along microtubules, to dock at nuclear pore complexes (NPCs), to release viral genomes from capsids, and to import viral genomes into the nucleoplasm, and that capsids lacking tegument cannot move along microtubules, but still bind to nuclear pores (<xref ref-type="bibr" rid="bib2">Anderson et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Ojala et al., 2000</xref>; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib100">Wolfstein et al., 2006</xref>).</p><p>Here, we searched for proteins that might contribute to sensing cytosolic capsids and thereby promote the detection of herpesviral genomes. Using extracts of matured THP-1 cells, a model system for human macrophages (<xref ref-type="bibr" rid="bib93">Tsuchiya et al., 1980</xref>) we identified type I interferon (IFN) inducible proteins that bound specifically to HSV-1 capsids. Among them was the large dynamin-like GTPase myxovirus resistance protein B (MxB). MxB limits the infection of several herpesviruses, and can mediate almost 50% of the IFN-mediated restriction of HSV-1, although its mode of action has remained elusive so far (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>, <xref ref-type="bibr" rid="bib58">Liu et al., 2012</xref>, <xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>, <xref ref-type="bibr" rid="bib48">Jaguva Vasudevan et al., 2018</xref>). MxB has been first described for its potent inhibition of HIV infection (<xref ref-type="bibr" rid="bib36">Goujon et al., 2013</xref>; <xref ref-type="bibr" rid="bib50">Kane et al., 2013</xref>, <xref ref-type="bibr" rid="bib59">Liu et al., 2013</xref>). The human <italic>MX2</italic> gene codes for a full-length MxB (residues 1–715) and a smaller version (residues 26–715) that lacks an N-terminal extension (NTE), which both are highly expressed upon IFN induction (<xref ref-type="bibr" rid="bib65">Melén et al., 1996</xref>). MxB likely operates as an anti-parallel dimer but can also form higher-order filaments; its N-terminal GTPase domain connects to a bundle signaling element that moves relative to the GTPase domain in response to nucleotide binding, and the C-terminal stalk domain is critical for MxB oligomerization (<xref ref-type="bibr" rid="bib1">Alvarez et al., 2017</xref>; <xref ref-type="bibr" rid="bib15">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Fribourgh et al., 2014</xref>; <xref ref-type="bibr" rid="bib34">Gao et al., 2011</xref>).</p><p>We show here that both, full-length MxB(1-715) and MxB(26-715) have the remarkable property to disassemble the capsids of the three human alphaherpesviruses HSV-1, HSV-2, and VZV, so that they can no longer transport nor shield the viral genomes. Capsid disassembly did not require proteases but depended on the ability of MxB to hydrolyse GTP and to dimerize. As the large tegument protein pUL36 links the capsid vertices to the other tegument proteins (<xref ref-type="bibr" rid="bib23">Crump, 2018</xref>; <xref ref-type="bibr" rid="bib24">Dai and Zhou, 2018</xref>; <xref ref-type="bibr" rid="bib25">Diefenbach, 2015</xref>), and as an increasing amount of associated tegument proteins protected capsids against MxB-mediated disassembly, we propose that MxB attacks the capsids at their vertices. Our data suggest that MxB can bind to and disassemble incoming as well as progeny capsids, and thereby might increase the sensing of cytosolic and nuclear viral genomes. Therefore, the MxB GTPase might be the sought-after capsid destroyer that acts upstream of cytosolic or nuclear sensors to promote viral genome detection and induction of innate immune responses.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>IFN induction prevents HSV-1 infection of macrophages</title><p>Before investigating capsid interactions with macrophage proteins, we compared HSV-1 infection in human keratinocytes (HaCat), pigment epithelial cells (RPE), and THP-1 cells at low, moderate, or high multiplicity of infection (MOI). We stimulated monocyte THP-1 cells with phorbol 12-myristate 13-acetate to differentiate them into a macrophage-like phenotype, and used them either directly (Mφ) or after a resting period of 3 days (Mφ<sub>R</sub>). HSV-1 replicated productively in HaCat and RPE cells up to 20 hpi, while a pre-treatment with IFN delayed and reduced but did not prevent the production of infectious virions (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Both Mφ and Mφ<sub>R</sub> released 10–100-fold less infectious HSV-1, and an IFN pre-treatment prevented infection at all MOIs. Thus, Mφ and Mφ<sub>R</sub> restricted HSV-1 infection efficiently, and the induction of IFN-stimulated genes (ISGs) prevented any productive infection.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>IFN restricts HSV-1 infection in keratinocytes, epithelial cells, and macrophages.</title><p>HaCat, RPE, Mφ, or Mφ<sub>R</sub> cells were mock-treated or treated with human IFN-α (1000 U/mL) for 16 hr and were infected with HSV-1(17<sup>+</sup>)Lox at 2.5 × 106 (MOI 5), 2.5 × 107 (MOI 50), or 5 × 107 PFU/mL (MOI 100), and the amount of cell-associated and extracellular virions was titrated on Vero cells. Each data point represents the mean of the three technical replicates of the combined cell-associated and extracellular titers. The error bars represent the standard deviation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig1-v2.tif"/></fig></sec><sec id="s2-2"><title>IFN-induced protein changes in the cytosol of macrophages</title><p>To identify cytosolic macrophage proteins that might foster or restrict HSV-1 capsid functions, we prepared extracts from Mφ<sub>R</sub> or IFN-induced Mφ<sub>IFN</sub> to reconstitute capsid-host protein complexes as they might assemble in macrophages (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Using subcellular fractionation and subsequent dialysis (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2A</xref>), we depleted the extracts of nuclei and mitochondria (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2B</xref>; pellet P1), cytoplasmic membranes such as Golgi apparatus, endoplasmic reticulum and plasma membrane (P1, P2), and small metabolites (S2, S3, S4). Furthermore, most of the cytoskeletal tubulin and actin sedimented into the first pellet (P1), while glyceraldehyde 3-phosphate dehydrogenase (GAPDH), a bona-fide cytosolic protein, remained soluble in the supernatants (S1, S2, S2’, S3, S4). Next, we analyzed the proteomes of the Mφ<sub>R</sub> and IFN-induced Mφ<sub>IFN</sub> cytosols at low ATP/GTP concentration [ATP/GTP<sup>low</sup>] by mass spectrometry (MS; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). We detected 494 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>; black circles) of more than 600 reported IFN-inducible proteins (<xref ref-type="bibr" rid="bib78">Rusinova et al., 2013</xref>). Of those, a Fisher’s exact test identified the interferomeDB, and in particular GALM, COL1A1, LGALS3BP, NT5C3A, IFI44, IFIT2, IFIT3, GBP4, SRP9, IFIT5, DSP, and L3HYPDH as enriched by at least 2.8-fold (log<sub>2</sub> 1.5) in the Mφ<sub>IFN</sub> cytosol (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2C</xref>; red). These changes might reflect IFN-induced transcriptional or translational regulation, post-translational modification, subcellular localization, or susceptibility to proteolysis, and show that the IFN induction had changed the cytosol proteome of the Mφ<sub>IFN</sub>.</p></sec><sec id="s2-3"><title>HSV-1 capsids interact with specific cytosolic macrophage proteins</title><p>To search for cytosolic Mφ proteins whose interactions with HSV-1 capsids depend on their surface composition, we generated tegumented viral V<sub>0.1</sub>, V<sub>0.5</sub>, and V<sub>1</sub> capsids as well as D capsids with a reduced tegumentation (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). For this, we lysed extracellular particles released from HSV-1 infected cells with non-ionic detergent to solubilize the envelope proteins and lipids, and in the presence of 0.1, 0.5, or 1 M KCl to modify intra-tegument protein-protein interactions (<xref ref-type="bibr" rid="bib2">Anderson et al., 2014</xref>; <xref ref-type="bibr" rid="bib69">Ojala et al., 2000</xref>; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>; <xref ref-type="bibr" rid="bib100">Wolfstein et al., 2006</xref>, <xref ref-type="bibr" rid="bib103">Zhang and McKnight, 1993</xref>). Furthermore, we dissociated tegument from V<sub>0.1</sub> capsids by a limited trypsin digestion to generate so-called D capsids. We then incubated similar amounts of different capsid types as calibrated by immunoblot for the major capsid protein VP5 (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2D</xref>) with cytosol at ATP/GTP<sup>low</sup> from Mφ<sub>R</sub> or IFN-induced Mφ<sub>IFN</sub> for 1 hr at 37 °C. The capsid-host protein complexes assembled in vitro were harvested by sedimentation, and their interactomes were determined by quantitative MS (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). As before (<xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib87">Snijder et al., 2017</xref>), the protein intensities were normalized across samples to the abundance of the major capsid protein VP5 (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>, host; <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>, viral).</p><p>Of 2,983 proteins identified (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>), we detected 1816 in at least three of the four replicates in any of the eight different capsid-host protein complexes. Of those, 598 host proteins bound differentially to one capsid type over another (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>; fold change ≥2 (log<sub>2</sub> 1); permutation-based FDR ≤ 0.05). The HSV-1 capsids had recruited specifically 279 proteins of Mφ<sub>R</sub> and 390 of Mφ<sub>IFN</sub> cytosol of which 71 were shared. Hierarchical clustering analyses of the associated Mφ<sub>R</sub> or Mφ<sub>IFN</sub> proteins identified four major classes; for example one enriched on V over D capsids (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplements 3</xref>–<xref ref-type="fig" rid="fig2s4">4</xref>, top green) and one enriched on D over V capsids (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplements 3</xref>–<xref ref-type="fig" rid="fig2s4">4</xref>, bottom violet). Therefore, we further compared the capsid-host interactions of D capsids directly to V<sub>0.1</sub> (<xref ref-type="fig" rid="fig2">Figure 2A, D</xref>), V<sub>0.5</sub> (<xref ref-type="fig" rid="fig2">Figure 2B and E</xref>), or V<sub>1</sub> (<xref ref-type="fig" rid="fig2">Figure 2C and F</xref>) capsids, and identified 82 proteins of Mφ<sub>R</sub> (<xref ref-type="fig" rid="fig2">Figure 2A, B and C</xref>) and 141 of Mφ<sub>IFN</sub> (<xref ref-type="fig" rid="fig2">Figure 2D, E and F</xref>) with 35 being shared (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>; difference ≥2.83 fold (log<sub>2</sub> 1.5); FDR ≤ 0.01). The Mφ<sub>R</sub> capsid-host complexes included 12 and the ones of Mφ<sub>IFN</sub> 19 proteins listed in the interferome database (<xref ref-type="bibr" rid="bib78">Rusinova et al., 2013</xref>; red in <xref ref-type="fig" rid="fig2">Figure 2</xref>). Gene ontology and pathway enrichment analyses showed that the identified 82 Mφ<sub>R</sub> (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>) and 141 Mφ<sub>IFN</sub> (<xref ref-type="fig" rid="fig3">Figure 3</xref>) proteins included many proteins implicated in innate immunity, intracellular transport, nucleotide and protein metabolism, as well as intracellular signaling. Overall, the host proteomes of V<sub>0.1</sub> (red) and D (gray) capsids were rather distinct, but more similar for V<sub>0.5</sub> (blue) and V<sub>1</sub> (green) capsids (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>). For example, V<sub>0.1</sub> capsids had recruited specifically the innate immunity proteins PIGR, IGHA1, BPIFA1 and DEFA3, but D capsids LRRFIP1, UFC, C3 and DCD from Mφ<sub>R</sub> cytosol. In Mφ<sub>IFN</sub>, the D capsids were enriched for C3, C6, IGBP1, UBA5, UBXN1, UBE3A, and RNF123. These data suggest that protein domains displayed on different capsids interacted with specific cytosolic Mφ<sub>R</sub> or Mφ<sub>IFN</sub> proteins.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Cytosolic IFN-induced macrophage proteins binding to HSV-1 capsids.</title><p>Volcano plots of iBAQs counts of proteins identified in capsid-host protein complexes assembled in cytosol from resting THP-1 φ cells (A - C) or treated with interferon-α (D - F) using V<sub>0.1</sub> (<bold>A, D</bold>), V<sub>0.5</sub> (<bold>B, E</bold>), or V<sub>1</sub> (<bold>C, F</bold>) capsids in comparison to D capsids. Proteins identified as highly specific interactions are indicated with larger symbols (log<sub>2</sub> difference ≥1.5; Welch’s t-test, two-tailed, permutation-based FDR ≤ 0.01); those with a log<sub>2</sub> difference ≥4 are annotated. ISGs (interferome.org) are indicated by filled black circles, and are annotated in red if significantly enriched (permutation-based FDR ≤ 0.05, and log<sub>2</sub> difference ≥1.5). Proteins with a q-value = 0 were imputed to - log<sub>10</sub> q-value = 3.1 (maximum of the graph), and were indicated with empty circles.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Experimental strategy to generate host protein-capsid complexes.</title><p>Tegumented viral V<sub>0.1</sub>, V<sub>0.5</sub>, or V<sub>1</sub> capsids (red) were isolated from extracellular particles released from BHK-21 cells infected with HSV-1(17<sup>+</sup>)Lox. They were lysed in 1% Triton X-100 to solubilize the viral envelope, and to extract different amounts of tegument (green) in the presence of 0.1 M, 0.5 M, or 1 M KCl. D capsids were generated from V<sub>0.1</sub> capsids by mild trypsin digestion. These different capsid types were purified through sucrose cushions. Tegument-free nuclear A, B, and C capsids were isolated from the nuclei of BHK cells infected with HSV-1(17<sup>+</sup>)Lox by gradient sedimentation. The capsids were resuspended in BRB80 buffer, treated with benzonase to degrade DNA and RNA, sedimented again, and incubated with cytosol fractions (yellow) from control or IFN-induced macrophages (THP-1 φ) or epithelial A549 cells. After sedimentation through sucrose cushions, the capsid-host protein complexes were analyzed by mass spectrometry (MS), immunoblot, or electron microscopy (EM). PNS, post-nuclear-supernatant; ND, nocodazole.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Characterization of macrophage subcellular fractionation.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-76804-fig2-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Characterization of cytosolic extracts and calibration of capsids.</title><p>(<bold>A</bold>) Cytosols were prepared from rested Mφ<sub>R</sub> or IFN-induced Mφ<sub>IFN</sub> macrophage cells. After swelling in hypotonic buffer, the cells were homogenized (<bold>L</bold>), and nuclei and mitochondria were sedimented (<bold>P1</bold>). The post-nuclear supernatant (<bold>S1</bold>) was adjusted to isotonic salt concentration, and centrifuged to sediment membrane compartments (<bold>P2</bold>), like the PM, ER and GA. To control the nucleotide concentration, the cytosols (<bold>S2</bold>) were dialyzed against a 7 kDa membrane prior to the addition of an ATP regeneration system (<bold>S2’</bold>). The remaining actin filaments and microtubules were sedimented in P3 to obtain a soluble cytosol fraction (<bold>S3</bold>). To reduce ATP and GTP levels, some cytosols were treated with 10 U/mL of apyrase (<bold>S4</bold>). Nocodazole (ND) was added to prevent polymerization and sedimentation of microtubules. (<bold>B</bold>) All fractions generated were analyzed by immunoblot for the respective compartment marker proteins as indicated. Nup, nucleoporins. MW, Molecular Weight (kDa). (<bold>C</bold>) Volcano plot summarizing the effect of IFN induction on the cytosol proteome. ISGs associated with the interferomeDB were enriched in cytosol from Mφ<sub>IFN</sub> as compared to Mφ<sub>R</sub> with an FDR of 7.96 × 10<sup>–7</sup> and an FC ≥2 in at least 1 experiment (Fisher’s exact test). IFN-inducible proteins are indicated by black circles, and those with an abundance log<sub>2</sub> difference ≥1.5 (vertical lines), and an uncorrected p-value &lt; 0.05 (horizontal line) are labeled in red. (<bold>D</bold>) The slot blot used for the estimation of capsid concentrations (capsids equivalent; CAP<sub>eq</sub>) of all preparations was labeled with anti-capsid antibodies (rabbit pAb SY4563) and adjusted to a calibration curve of a standard preparation.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>HSV-1 capsids interactomes.</title><p>Unbiased hierarchical clustered heat map showing the log<sub>2</sub> fold changes of host proteins identified from capsids-host protein sediments (c.f. <xref ref-type="fig" rid="fig2">Figure 2</xref>; abundance log<sub>2</sub> difference larger than 1; significance permutation-based FDR smaller than 0.05) from (<bold>A</bold>) cytosol of resting Mφ, or (<bold>B</bold>) IFN-induced Mφ<sub>IFN</sub> macrophages. For each protein, the fold change was calculated based on their abundance (iBAQs) in V<sub>1</sub>, V<sub>0.5</sub>, or V<sub>0.1</sub> capsids compared to D capsids using a linear scale from violet being the lowest to dark green being the highest.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 4.</label><caption><title>HSV-1 capsids interactomes.</title><p>Unbiased hierarchical clustered heat map showing the log<sub>2</sub> fold changes of host proteins identified from capsids-host protein sediments (c.f. <xref ref-type="fig" rid="fig2">Figure 2</xref>; abundance log<sub>2</sub> difference larger than 1; significance permutation-based FDR smaller than 0.05) from (<bold>A</bold>) cytosol of resting macrophages (M<sub>φ</sub>), or (<bold>B</bold>) IFN-induced macrophages (M<sub>φIFN</sub>). For each protein, the fold change was calculated based on their abundance (iBAQs) in V<sub>1</sub>, V<sub>0.5</sub>, or V<sub>0.1</sub> capsids compared to D capsids using a linear scale from violet being the lowest to dark green being the highest.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig2-figsupp4-v2.tif"/></fig></fig-group><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Cytosolic proteins of IFN-induced macrophages binding to HSV-1 capsids.</title><p>Host proteins from cytosol of IFN-stimulated Mφ<sub>IFN</sub> (c.f. D, E, F; abundance log<sub>2</sub> difference larger than 1.5; significance permutation-based FDR smaller than 0.01) interacting with V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub>, or D capsids were assembled into a functional interaction network of known protein-protein-interactions (gray lines; STRING database, confidence score of 0.7), and grouped according to their known functions (Gene Ontology, Pathway analysis). The Pie chart for each protein indicates its relative enrichment on V<sub>0.1</sub> (red), V<sub>0.5</sub> (blue), V<sub>1</sub> (green), or D capsids (gray).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Cytosolic proteins of resting macrophage binding to HSV-1 capsids.</title><p><italic>Host</italic> proteins from cytosol of resting Mφ (c.f. <xref ref-type="fig" rid="fig3">Figure 3A, B and C</xref>; abundance log<sub>2</sub> difference larger than 1.5; significance permutation-based FDR smaller than 0.01) interacting with V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub>, or D capsids were assembled into a functional interaction network of known protein-protein-interactions (grey lines; STRING database, confidence score of 0.7), and grouped according to their known functions (Gene Ontology, Pathway analysis). The Pie chart for each protein indicates its relative enrichment on V<sub>0.1</sub> (red), V<sub>0.5</sub> (blue), V<sub>1</sub> (green), or D capsids (grey).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig3-figsupp1-v2.tif"/></fig></fig-group><p>In these assays, the capsids interacted with several proteins already validated to promote or restrict HSV or VZV infection. Examples are the ESCRT-III co-factor VPS4 (<xref ref-type="bibr" rid="bib12">Cabrera et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Crump et al., 2007</xref>), EIF4H (<xref ref-type="bibr" rid="bib70">Page and Read, 2010</xref>), the Kif2a subunit of kinesin-13 (<xref ref-type="bibr" rid="bib94">Turan et al., 2019</xref>), the POLR1C subunit of RNA polymerase III (<xref ref-type="bibr" rid="bib14">Carter-Timofte et al., 2018</xref>), the DNA protein kinase PRKDC (<xref ref-type="bibr" rid="bib49">Justice et al., 2021</xref>), and DDX1 (<xref ref-type="bibr" rid="bib104">Zhang et al., 2011</xref>). Moreover, the deubiquitinase USP7 (<xref ref-type="bibr" rid="bib76">Rodríguez et al., 2020</xref>) and the ubiquitin ligases RNF123, TRIM72, UFC1 and UBE3A as well as the proteasome might regulate capsid functionality (<xref ref-type="bibr" rid="bib47">Huffmaster et al., 2015</xref>; <xref ref-type="bibr" rid="bib83">Schneider et al., 2021</xref>) or their degradation (<xref ref-type="bibr" rid="bib43">Horan et al., 2013</xref>; <xref ref-type="bibr" rid="bib90">Sun et al., 2019</xref>). These data show that HSV-1 capsids exposing a different tegument composition recruited specific cytosolic proteins from resting or IFN-induced macrophages.</p></sec><sec id="s2-4"><title>HSV-1 capsids recruit specific proteins responding to or regulating type I IFN</title><p>We next analyzed the Mφ<sub>IFN</sub> samples in detail as IFN induction had prevented HSV-1 infection completely. We generated cluster maps for the 32 capsid-associated proteins belonging to the GO clusters <italic>Response to type I IFN</italic> or <italic>Regulation of type I IFN production</italic> (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). V capsids recruited DHX9, HSPD1, and FLOT1 as well as proteins involved in the DNA damage response like PRKDC/DNA-PK, XRCC5, and XCCR6 from both, Mφ<sub>R</sub> and Mφ<sub>IFN</sub> cytosol (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Interestingly, V capsids bound specifically to STAT1 in Mφ<sub>R</sub>, but to ADAR and IFIT2 in Mφ<sub>IFN</sub> cytosol. D capsids were enriched for IFI16, OAS2, POLR1C, STAT2, and MxB (gene Mx2) in Mφ<sub>IFN</sub> but not in Mφ<sub>R</sub> (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Particularly interesting was the discovery of MxB in these capsid-host protein complexes. MxB was significantly enriched on HSV-1 D capsids in Mφ<sub>IFN</sub> cytosol, and the IFN treatment had the strongest impact on the interaction of MxB with capsids. Moreover, the calculated enrichment score for MxB on capsids was very high, although the MxB levels in the input cytosol were below the detection limit (undetected, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). MxB but not its homolog MxA restricts infections of the herpesviruses HSV-1, HSV-2, MCMV, KSHV, and MHV-68, but its mode of action has not been elucidated (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>, <xref ref-type="bibr" rid="bib58">Liu et al., 2012</xref>, <xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>, <xref ref-type="bibr" rid="bib48">Jaguva Vasudevan et al., 2018</xref>). For these reasons, we investigated the interaction of human MxB with HSV-1 capsids further.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>HSV-1 capsids associate with proteins involved in type I IFN response.</title><p>Unbiased hierarchical clustered heat map showing the log<sub>2</sub> fold changes of IFN-induced proteins (GO type-I IFN) identified from capsids-host protein sediments from cytosol of resting Mφ, or IFN-induced Mφ<sub>IFN</sub> macrophages. For each protein, the fold change was calculated based on their abundance (iBAQs) in V<sub>1</sub>, V<sub>0.5</sub>, and V<sub>0.1</sub> capsids as compared to their abundance in D capsids, using a linear scale from violet being the lowest to dark green being the highest. (*) and (**) design the proteins with an FDR corrected p-value ≤ 0.05 and ≤ 0.01, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>HSV-1 capsids binds to a few ISG proteins.</title><p>Box and whisker plot of iBAQs showing the differential detection of PRKDC, DHX9, FLOT1, IFI16, STAT1, XRCC5, XRCC6, HSPD1, IFIT2, SHMT2, HLA-A, ADAR, IFIT3, OAS2, POLR1C and MxB[MX2] in D, V<sub>1</sub>, V<sub>0.5</sub>, and V<sub>0.1</sub> capsids-host protein sediments after incubation in (<bold>A</bold>) cytosol of resting MφR macrophages, (<bold>B</bold>) IFN-induced MφIFN macrophages or (<bold>C</bold>) no cytosol. (*) design the significant binding to D or V0.1, V0.5, and V1 capsids as assessed by Welch’s t-test (two-tailed, permutation-based FDR ≤ 0.05) comparing D vs V<sub>0.1</sub>, V<sub>0.5</sub>, or V<sub>1</sub> capsids in each cytosol separately.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig4-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-5"><title>MxB binds to capsids</title><p>We first characterized the MxB fractionation behavior during the cytosol preparation (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). As reported (<xref ref-type="bibr" rid="bib36">Goujon et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Melén et al., 1996</xref>), MxB was upregulated in IFN-induced Mφ<sub>IFN</sub>. MxB sedimented with nuclei and mitochondria as reported before (<xref ref-type="bibr" rid="bib13">Cao et al., 2020</xref>), and also with cytoplasmic membranes. Moreover, MxB can assemble into cytosolic filaments (<xref ref-type="bibr" rid="bib1">Alvarez et al., 2017</xref>) which might have been sedimented on their own. Both, after the addition of ATP and GTP (ATP/GTP<sup>high</sup>) or the hydrolase apyrase (<xref ref-type="bibr" rid="bib72">Pilla et al., 1996</xref>; ATP/GTP<sup>low</sup>), a significant fraction of MxB remained soluble in the cytosol.</p><p>Next, we confirmed by immunoblotting that MxB co-sedimented with HSV-1 capsids which had been incubated in cytosols from Mφ<sub>R</sub> or Mφ<sub>IFN</sub>. In line with the MS results, MxB bound better to D than to V<sub>0.1</sub>, V<sub>0.5</sub>, or V<sub>1</sub> capsids (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). We next probed authentic nuclear capsids, namely empty A, scaffold-filled B, or DNA-filled C capsids, as well as tegumented V<sub>1</sub>, V<sub>0.5</sub>, V<sub>0.1</sub> or D capsids with cytosol of A549-MxB(1-715) epithelial cells expressing MxB(1-715). Nuclear A and C as well as V<sub>1</sub> and D capsids recruited MxB efficiently, while B, V<sub>0.1</sub> and V<sub>0.5</sub> capsids bound less MxB (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). MxB did not sediment by itself, and also did not associate with agarose beads used as another sedimentation control (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). These data indicate that MxB binds to specific structural features on the capsid surface.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Tegumentation reduces MxB binding to HSV-1 capsids.</title><p>The binding of MxB to viral V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub>, or D, or to nuclear A, B, or C capsids was analyzed after incubation in 0.2 mg/mL cytosol prepared from (A; <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>) THP-1 φ stimulated or not with IFN, or (B-C; <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>; <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>) A549 cells stably expressing MxA, MxB(1-715) full length, the short MxB(26-715), or MxB mutants defective in GTP-hydrolysis MxB(T151A), GTP-binding and hydrolysis MxB(K131A), or dimerization MxB(M574D). Sedimented capsid-host protein complexes were then analyzed by immunoblot for VP5 (capsid), MxB, MxA, and GAPDH as a loading control. As control cytosols were sedimented without capsids (A: sed), or with uncoated agarose beads (A, B: beads). The amounts of MxA/MxB found in the capsid-host protein complexes were quantified, and normalized to their respective VP5 levels. Error bars: SEM. summarized from three experiments. One asterisk denotes p &lt; 0.05, two asterisks indicate p &lt; 0.01 and three asterisks represent p &lt; 0.001 as determined by Welch’s t-tests comparisons.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Cytosolic MxB from THP-1 cells co-sediments with capsids in <xref ref-type="fig" rid="fig5">Figure 5A</xref>.</title><p>Tegument shields MxB binding sites on HSV-1 capsids in <xref ref-type="fig" rid="fig5">Figure 5B</xref>. MxB requires GTP binding, but no NTE, GTP hydrolysis or dimerization to bind capsids in <xref ref-type="fig" rid="fig5">Figure 5C</xref>.</p></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-76804-fig5-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig5-v2.tif"/></fig><p>In cells, MxB-mediated restriction of herpesvirus replication depends on its N-terminal 25 amino acid residues (NTE), its GTPase activity, and its capacity to form dimers (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Jaguva Vasudevan et al., 2018</xref>). We incubated capsids with cytosols containing Mx<underline>A</underline>, MxB(1-715), MxB(26-715) (<xref ref-type="bibr" rid="bib65">Melén et al., 1996</xref>; <xref ref-type="bibr" rid="bib66">Melén and Julkunen, 1997</xref>), MxB(K131A) with reduced GTP binding, MxB(T151A) lacking the GTPase activity, or MxB(M574D) unable to dimerize (<xref ref-type="bibr" rid="bib1">Alvarez et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Fribourgh et al., 2014</xref>; <xref ref-type="bibr" rid="bib55">King et al., 2004</xref>; <xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>). In contrast to MxA, MxB(1-175), MxB(26-715), and MxB(M574D) co-sedimented with capsids to a similar extent. Interestingly, MxB(K131A) did not bind to capsids, while MxB(T151A) bound even stronger (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). These data suggest that conformational changes associated with GTP binding or hydrolysis contribute to MxB interaction with HSV-1 capsids.</p></sec><sec id="s2-6"><title>MxB disassembles capsids of alphaherpesviruses</title><p>Next, we tested whether MxB might affect HSV-1 capsid stability. While the previous capsid sedimentation assays were performed at ATP/GTP<sup>low</sup>, they suggested that the GTP/GDP state of MxB might modulate its interaction with capsids. To test this experimentally, we supplemented the cytosols with 1 mM GTP, 1 mM ATP, and 7.5 mM creatine phosphate to maintain high ATP/GTP levels [ATP/GTP<sup>high</sup>]. We resuspended sedimented capsid-host protein complexes and applied them onto EM grids (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>), or we added isolated capsids directly onto EM grids and then placed them on a drop of cytosol to allow the formation of capsid-host protein complexes (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). This direct <italic>on-grid assay</italic> required 50 times fewer capsids than the <italic>sedimentation-resuspension assay</italic> and allowed for time-course analyses. For both, we negatively contrasted the samples with uranyl acetate and analyzed them by electron microscopy.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>MxB induces disassembly of herpesviral capsids.</title><p>(<bold>A</bold>) Experimental design: Capsids were adsorbed onto hydrophilic enhanced carbon-coated EM grids for 20 min at RT. The capsids were incubated in cytosol with ATP/GTP<sup>high</sup>, and the incubation was stopped at different times by extensive washing. The samples were analyzed by EM after negative staining with uranyl acetate. (<bold>B–D</bold>) Capsids after incubation in cytosol derived from rested Mφ or IFN-induced Mφ<sub>IFN</sub> macrophages, or control or MxB(1-715) A549 expressing cells for 1 hr at 37 °C, and classified as (<bold>B</bold>) intact, (<bold>C</bold>) punched or (<bold>D</bold>) disassembled flat phenotypes. The number of capsomers per flat particle was counted, and is displayed at the bottom of each figures. (<bold>E</bold>) Nuclear VZV capsids remain intact (Ei) after incubation in the cytosol of A549 control cells, or but appear punched (Eii) or as flat shells (Eiii, Eiv) after incubation in the cytosol of A549 cells expressing MxB. Scale bar: 50 nm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Capsid disassembly intermediates by anti-capsid immunoEM.</title><p><italic>Images</italic> of capsids after negative staining and labeling with antibodies raised against the major capsid protein VP5 (NC-1), after incubation in ATP-complemented cytosol from A549 control or MxB(1-715) expressing cells for 60 min at 37 °C, and classified as (<bold>A</bold>) <italic>intact</italic>, (<bold>B</bold>) <italic>punched</italic>, or (<bold>C</bold>) <italic>flattened</italic> shells. Scale bar: 50 nm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig6-figsupp1-v2.tif"/></fig></fig-group><p>When capsids were incubated with cytosol from A549 control cells not containing MxB, we saw mostly intact capsids with an appropriate diameter of about 125 nm, and an intact icosahedral morphology characterized by pentons at the vertices and hexons on the triangular capsid faces (<xref ref-type="fig" rid="fig6">Figure 6B</xref>). The capsids contained genomic DNA as the uranyl acetate used for negative contrast staining had not or only partially entered the capsid lumen. But a treatment with cytosol from IFN-induced Mφ<sub>IFN</sub> or A549-MxB(1-715) cells dramatically impaired the capsid shell. Based on different MxB-induced morphological changes, we classified the capsid structures that we had identified by immunolabeling for capsid proteins (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>) into three categories. <italic>Intact capsids</italic> (<xref ref-type="fig" rid="fig6">Figure 6B</xref>, Figure S6A) have an icosahedral morphology and include empty A, scaffold-filled B, and DNA-filled C capsids. <italic>Punched capsids</italic> are characterized by indentations on one or more vertices and an impaired icosahedral shape (<xref ref-type="fig" rid="fig6">Figure 6C</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>). <italic>Flat shells</italic> have completely lost their icosahedral shape (<xref ref-type="fig" rid="fig6">Figure 6D</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>). We estimated the number of capsomers on <italic>flat shells</italic> based on their area, and scored a structure with &lt;100 capsomers as a half capsid and with ≥100 as one capsid (numbers in <xref ref-type="fig" rid="fig6">Figure 6D</xref>). Cytosols containing MxB(1-715) also disassembled capsids of HSV-2 (not shown) or VZV (<xref ref-type="fig" rid="fig6">Figure 6E</xref>) to <italic>punched capsids</italic> and <italic>flat shells</italic>. As MxB induced capsid disassembly of HSV-1, HSV-2, and VZV, these experiments suggest that MxB restricts the infection of herpesviruses by targeting their capsids.</p></sec><sec id="s2-7"><title>MxB requires GTP hydrolysis and dimerization to attack herpesviral capsids</title><p>Next, we further characterized the capsid disassembly activity of MxB by quantitative electron microscopy. Cytosol from IFN-induced Mφ<sub>IFN</sub> disassembled more than 80% of the capsids within 1 hr while resting Mφ<sub>R</sub> disassembled only about 40% (<xref ref-type="fig" rid="fig7">Figure 7A</xref>). Cytosol derived from A549 control cells had a minor effect on capsids, while cytosol from A549-MxB(1-715) cells disassembled capsids almost as efficiently as cytosol from Mφ<sub>IFN</sub>. Spiking cytosol from A549 control cells with an increasing percentage of A549-MxB(1-715) cytosol led to an increasing capsid disassembly with a majority of <italic>punched capsids</italic>, at 50% or 66% MxB cytosol, while incubation in pure A549-MxB(1-715) cytosol lead to more than 95% disassembly to mostly <italic>flat shells</italic> within 1 hr of incubation (<xref ref-type="fig" rid="fig7">Figure 7B</xref>). We then asked whether MxB had activated other host proteins to mediate capsid disassembly, or whether it was directly responsible. We prepared cytosol from A549-MxB(1-715)-MxB(26-715) expressing both untagged MxB proteins, or from A549-MxB-FLAG expressing both MxB(1-715)-FLAG and MxB(26-715)-FLAG. Both cytosols promoted capsid disassembly (MxB; MxB-FLAG in <xref ref-type="fig" rid="fig7">Figure 7C</xref>). An immunodepletion with anti-FLAG antibodies removed only the FLAG-tagged MxB proteins (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>), and accordingly the disassembly activity from the A549-MxB-FLAG cytosol (MxB-FLAG FT), but not from the A549-MxB(1-715)-MxB(26-715) cytosol (MxB FT) containing both untagged MxB proteins.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>MxB GTP hydrolysis and dimerization required for capsid disassembly and vDNA release of viral genomes.</title><p>HSV-1 (<bold>A–H</bold>), HSV-2 (<bold>G</bold>) or VZV capsids (<bold>G</bold>) were incubated with cytosol at ATP/GTP<sup>high</sup> for 1 hr or the indicated time (<bold>E,F</bold>) at 37 °C, and classified into <italic>intact, punched</italic> and <italic>flat</italic> capsids by electron microscopy (<bold>A–G</bold>), or the amount of released viral DNA was measured by qPCR (<bold>H</bold>). (<bold>A</bold>) Quantification of <italic>punched</italic> and <italic>flat</italic> D capsid shells in cytosol prepared from rested Mφ or IFN-induced Mφ<sub>IFN</sub> macrophages, or from control A549 (mock) or A549-MxB(1-715) cells. (<bold>B</bold>) Increasing amounts of MxB(1-715) [%] were added to control A549 cytosol, and the amounts of <italic>punched</italic> and <italic>flat</italic> capsids were quantified after incubation in these mixtures. (<bold>C</bold>) Cytosols of A549 cells expressing MxB(1-715) and Mx(25-715) or MxB(1-715)-FLAG and MxB(26-715)-FLAG were incubated with anti-FLAG antibodies coupled to magnetic beads, the flow-through fractions (FT) were harvested, capsids were treated with anti-FLAG treated or control cytosols, and the amount of punched and flat capsids were quantified. (<bold>D</bold>) Capsids were incubated in cytosols prepared from A549 cells expressing full-length (FL) MxB(1-715), MxB(26-715), MxB(K131A), MxB(T151A), or MxB(M574D) at ATP/GTP<sup>low</sup> or ATP/GTP<sup>high</sup> levels. (<bold>E</bold>) Time-course of MxB-induced disassembly of capsids pre-adsorbed onto EM grids, incubated with cytosol from A549-MxB(1-715). (<bold>F</bold>) Analysis of D, V<sub>0.5</sub>, or V<sub>0.1</sub> capsids treated with MxB(1-175) cytosol for <italic>broken</italic> (<italic>punched +flat</italic>) capsids after negative stain and EM as described for panel E. (<bold>G</bold>) Quantification of MxB cytosol disassembly of D capsids of HSV-1(17<sup>+</sup>)Lox, HSV-1(KOS), or HSV-2(333), or nuclear C capsids of VZV, after incubation in cytosol from A549-MxB(1-715) cells. (<bold>H</bold>) D capsids were incubated with different cytosols for 1 hr at 37 °C or treated with 1% SDS and 10% Tx-100 only, and the released DNA not protected by capsid shells was quantified by qPCR. Error bars: SEM from 100 capsids in three biological replicates. One symbol of *or § denotes p &lt; 0.05, two p &lt; 0.01, and three p &lt; 0.001 as determined in One-way analysis of variance with a Bonferroni post-test, and comparing the relative amounts of (*) <italic>punched</italic> and (§) <italic>flat</italic> capsids, or indicating the differences with the mock-treated samples (*).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Cytosol immunodepleted for MxB.</title><p>Cytosols prepared from A549-MxB(1-715) and MxB(26-715) expressing MxB(1-715) and MxB(26-715), or A549-MxB-FLAG cells expressing MxB(1-715)-FLAG and MxB(26-715)-FLAG, respectively, were incubated with agarose beads coupled to anti-FLAG antibodies. After immunodepletion with anti-FLAG beads to deplete MxB(1-715)-FLAG and MxB(26-715)-FLAG, the flow through (FT) was harvested. To determine to what extend the FLAG-tagged MxB proteins had been depleted, the starting cytosols (MxB, Mxb-FLAG) as well as the respective FT fractions were probed by immunoblot using antibodies directed against MxB, FLAG, or GAPDH as a loading control. <xref ref-type="supplementary-material" rid="fig7s1sdata1">Figure 7—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Western blot of MxB immunodepletion.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-76804-fig7-figsupp1-data1-v2.zip"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig7-figsupp1-v2.tif"/></fig></fig-group><p>We next tested at ATP/GTP<sup>high</sup> the effect of various MxB mutants on HSV-1 capsid stability. While full-length MxB(1-715) induced capsid disassembly, the MxB mutants impaired in GTPase activity (T151A), GTP binding (K131A), or dimerization (M574D) as well as cytosol with MxB at ATP/GTP<sup>low</sup> did not (<xref ref-type="fig" rid="fig7">Figure 7D</xref>). In contrast, the smaller MxB(26-715) protein lacking the NTE retained about 50% of the capsid disassembly activity. Furthermore, studying the stability of capsids pre-adsorbed <italic>on-grid</italic> in a time-course revealed a lag phase of about 30 min until broken capsids appeared with increasing rate (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). The percentage of <italic>punched capsids</italic> reached a plateau at 50 min, while the amount of <italic>flat shells</italic> continued to increase (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). Further experiments showed that MxB attacked D capsids more efficiently than tegumented V<sub>0.5</sub> capsids, of which about 70% resisted the MxB attack (<xref ref-type="fig" rid="fig7">Figure 7F</xref>). In contrast, the V<sub>0.1</sub> capsids seemed to be spared from MxB attack, since no broken capsids appeared within an 1 hr treatment. Since MxB restricts infection of several herpesviruses (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>, <xref ref-type="bibr" rid="bib58">Liu et al., 2012</xref>, <xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>, <xref ref-type="bibr" rid="bib48">Jaguva Vasudevan et al., 2018</xref>), we compared the impact of MxB on D capsids from HSV-1(17<sup>+</sup>)Lox, HSV-1(KOS), HSV-2(333), or on nuclear C capsids from VZV(rOka). Capsids of these human alphaherpesviruses were all susceptible to MxB attack (<xref ref-type="fig" rid="fig7">Figure 7G</xref>).</p></sec><sec id="s2-8"><title>MxB attack leads to the release of viral genomes from capsids</title><p>Next, we determined how well the capsid shells protected the viral genomes against a DNA nuclease digestion. Capsids released three or two times more viral genomes in cytosols from MxB(1-715) or MxB-FLAG than from control or MxB(M574D) cells (<xref ref-type="fig" rid="fig7">Figure 7H</xref>). Together, these data indicate that the MxB GTPase disassembles the capsid shells and induces a release of viral DNA of several herpesviruses. Our experiments suggest that GTP binding and hydrolysis as well as dimerization contribute to MxB-mediated disassembly of alphaherpesvirus capsids. Its slow start with a lag of about 30 min indicates that the capsid attack might require some nucleating or cooperative reaction to assemble active MxB oligomers or an MxB-containing complex onto capsids.</p></sec><sec id="s2-9"><title>Tegument proteins protect against MxB attack</title><p>As complete tegumentation shielded V<sub>0.1</sub> capsids against destruction, while MxB bound to surface features exposed on V<sub>0.5</sub>, A, C and D capsids, we compared the proteomes of the V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub>, and D capsids. We calibrated the relative abundances of the 58 HSV-1 proteins detected to the normalized amounts of the major capsid protein VP5. The tegument compositions of V<sub>0.1</sub>, V<sub>0.5</sub>, and V<sub>1</sub> capsids were similar to each other but different from D capsids (<xref ref-type="fig" rid="fig8">Figure 8</xref>). The bona-fide capsid proteins VP21, VP24, VP22a, VP19c, and VP23 varied little among all capsid types. However, D capsids contain a bit less capsid surface proteins; namely VP26, the capsid specific vertex components (CSVC) pUL17 and pUL25, and to some extent the portal pUL6, and less of the major tegument proteins VP22, VP13/14, VP16, VP11/12 as well as other tegument proteins with ICP0, pUL36, and pUL37 being most susceptible to the trypsin treatment. Overall, there were little differences in the relative tegument protein amounts among V<sub>0.5</sub> and V<sub>1</sub> capsids. In contrast, V<sub>0.1</sub> capsids contained more tegument proteins, for example VP13/14, pUS3, and pUL16. All capsid preparations contained traces of membrane proteins and nuclear HSV-1 proteins contributing to DNA replication and packaging (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). These data further validated that a treatment with 0.5 or 1 M KCl during the detergent lysis of virions destabilized intra-tegument interactions. Furthermore, the limited trypsin digestion had reduced the capsid proteome further and increased the susceptibility to MxB attack.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Structural and tegument characterization of V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub>, and D capsids.</title><p>The composition of HSV-1(17<sup>+</sup>)Lox derived V<sub>0.1</sub> (red), V<sub>0.5</sub> (blue), V<sub>1</sub> (green), and D (gray) capsids was analyzed by quantitative mass spectrometry in four biological replica. The sum of all the peptides intensities (iBAQ, intensity-based absolute quantification) of each viral protein known to participate in the structure of the capsids was normalized to the one of VP5 and displayed in a bar plot for each viral protein.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Membrane and non-structural proteins on V capsids versus D capsids.</title><p>The composition of HSV-1 derived V<sub>0.1</sub> (red), V<sub>0.5</sub> (blue), V<sub>1</sub> (green), and D (gray) capsids were analyzed by quantitative mass spectrometry in four biological replicates. The sum of all the peptides intensities (iBAQ, intensity-based absolute quantification) of each viral protein unknown to participate in the structure of the capsids was normalized to the one of VP5 and displayed in a bar plot.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-76804-fig8-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Cell-type-specific defence mechanisms shape the arms race between proteins restricting or promoting nuclear targeting of incoming viral capsids and viral genome release into the nucleoplasm. We have developed biochemical assays to investigate functional interactions of viral capsids with host cell structures (<xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>), and analyzed here HSV-1 capsid-host protein complexes assembled in cytosols from resting Mφ<sub>R</sub> or IFN-induced Mφ<sub>IFN</sub> cells. We show that the IFN-inducible MxB GTPase bound to alphaherpesviral capsids, most likely to structural features around the capsid vertices, and disassembled herpesvirus capsids in a GTP-dependent fashion, and so that they no longer shielded the viral genomes. Capsid disassembly by MxB could reduce nuclear targeting of incoming capsids and genomes, but stimulate the activation of cytosolic DNA sensors and innate immune responses.</p><sec id="s3-1"><title>Cytosolic IFN-induced macrophage proteins binding to HSV-1 capsids</title><p>IFN induction prevented HSV-1 infection of Mφ, and increased the cytosolic abundance of at least 12 proteins listed in the interferome database (<xref ref-type="bibr" rid="bib78">Rusinova et al., 2013</xref>). Here, we assembled host protein-capsid complexes from HSV-1 capsids and cytosols of Mφ or Mφ<sub>IFN</sub> cells as they might also form in cells. While our MS analyses showed that V<sub>0.5</sub> and V<sub>1</sub> capsids recruited unique but also common proteins, the proteomes of V<sub>0.1</sub> and D capsids were more distinct. These specific interactions are consistent with the notion that a treatment with 0.5 or 1 M KCl during the detergent lysis of virions destabilized intra-tegument interactions, that influenced, for example, the recruitment of dynactin, kinesin-1, and kinesin-2 from brain cytosol (<xref ref-type="bibr" rid="bib69">Ojala et al., 2000</xref>; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib100">Wolfstein et al., 2006</xref>). Moreover, these results are consistent with immunoelectron microscopy data showing that the surface of distinct V capsid types display different tegument epitopes (<xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>), and with cryoelectron tomography data revealing diminishing tegument densities from V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub>, capsids to C capsids (<xref ref-type="bibr" rid="bib2">Anderson et al., 2014</xref>). Thus, the surface features of V<sub>0.1</sub>, V<sub>0.5</sub>, and V<sub>1</sub> capsids differ as indicated by cryoelectron tomography, binding of anti-tegument antibodies, and the recruitment of distinct sets of cytosolic proteins from brain tissue (<xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>), or macrophages as shown here. Host proteins may bind to viral proteins in both states, when they are soluble in the cytosol or the nucleoplasm, or when they are associated with capsids. From host proteins shown here to bind to capsids, direct interactions with tegument proteins have already been reported; for example USP7 binding to ICP0 (<xref ref-type="bibr" rid="bib30">Everett et al., 1997</xref>) or EIF4H binding to vhs (pUL41; <xref ref-type="bibr" rid="bib70">Page and Read, 2010</xref>). Furthermore, proteins involved in intracellular trafficking or virus assembly associated particularly with tegumented V capsids. For example, importin α5 (<italic>KPNA1</italic>) might mediate capsid targeting to the nuclear pores (<xref ref-type="bibr" rid="bib27">Döhner et al., 2018</xref>; <xref ref-type="bibr" rid="bib28">Döhner et al., 2021</xref>), while RAB1B contributes to the envelopment of cytosolic HSV-1 capsids (<xref ref-type="bibr" rid="bib102">Zenner et al., 2011</xref>).</p></sec><sec id="s3-2"><title>MxB binding to alphaherpesviral capsids</title><p>In addition to MxB, the host-capsid complexes included other antiviral proteins which in turn might be counteracted by HSV-1 proteins. Several Mφ<sub>IFN</sub> proteins already know to restrict herpesviruses, for example STAT2, POLR1C, IFI16, DDX58 (RIG-I), and OAS2 (<xref ref-type="bibr" rid="bib57">Kurt-Jones et al., 2017</xref>; <xref ref-type="bibr" rid="bib62">Lum and Cristea, 2021</xref>; <xref ref-type="bibr" rid="bib63">Ma et al., 2018</xref>), bound preferentially to D capsids. As it was not known how MxB might restrict herpesviral infection (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Jaguva Vasudevan et al., 2018</xref>), we investigated its association with capsids further. B capsids are less sturdy and have not undergone the structural changes that stabilize the A and C capsids (<xref ref-type="bibr" rid="bib77">Roos et al., 2009</xref>; <xref ref-type="bibr" rid="bib79">Sae-Ueng et al., 2014</xref>; <xref ref-type="bibr" rid="bib87">Snijder et al., 2017</xref>). Intriguingly, this stabilization depends on the CSVC proteins pUL17 and pUL25 (<xref ref-type="bibr" rid="bib79">Sae-Ueng et al., 2014</xref>; <xref ref-type="bibr" rid="bib87">Snijder et al., 2017</xref>), which are present on B, A, and C capsids (<xref ref-type="bibr" rid="bib2">Anderson et al., 2014</xref>; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib87">Snijder et al., 2017</xref>). As MxB bound to A, C and D, but not to B capsids, it might recognize surface features formed during capsid stabilization, e.g. matured CSVCs or portals, which are increasingly shielded on tegumented V<sub>1</sub>, V<sub>0.5</sub>, and V<sub>0.1</sub> capsids.</p><p>Mx<underline>A</underline> and Mx<underline>B</underline> GTPases inhibit several viruses by blocking early steps of infection (<xref ref-type="bibr" rid="bib39">Haller et al., 2015</xref>). MxB binding to HIV capsids depends on its N-terminal region (NTR) of about 90 residues and the GTPase domain (<xref ref-type="bibr" rid="bib6">Betancor et al., 2019</xref>; <xref ref-type="bibr" rid="bib33">Fricke et al., 2014</xref>; <xref ref-type="bibr" rid="bib86">Smaga et al., 2019</xref>; <xref ref-type="bibr" rid="bib101">Xie et al., 2021</xref>). Similarly, HSV-1 capsids bound MxB(1-715) and to a lesser extent MxB(26-715). But in contrast to HIV capsids (<xref ref-type="bibr" rid="bib6">Betancor et al., 2019</xref>; <xref ref-type="bibr" rid="bib101">Xie et al., 2021</xref>), HSV-1 capsids recruited also the GTPase deficient MxB(T151A) and the monomeric MxB(M574D). These data indicate that the interaction of MxB with HSV-1 capsids depends on the NTE of 25 residues, its GTP/GDP status, but not on its dimerization.</p></sec><sec id="s3-3"><title>MxB induced disassembly of alphaherpesviral capsids</title><p>HSV-1 capsid disassembly did not require proteolysis as the cytosols contained protease inhibitors, but may be modulated by other host proteins as there was a considerable lag phase. MxB did not attack fully tegumented V<sub>0.1</sub> capsids, while V<sub>0.5</sub> or D capsids were more susceptible. The large tegument protein pUL36 links other tegument proteins to the capsids; it is tightly associated with pUL17 and pUL25 at the CSVCs at the pentons, and it extends toward the twofold symmetry axes connecting neighboring capsid faces (<xref ref-type="bibr" rid="bib18">Coller et al., 2007</xref>, <xref ref-type="bibr" rid="bib60">Liu et al., 2017</xref>, <xref ref-type="bibr" rid="bib68">Newcomb and Brown, 1991</xref>, <xref ref-type="bibr" rid="bib77">Roos et al., 2009</xref>, <xref ref-type="bibr" rid="bib82">Schipke et al., 2012</xref>). Our electron microscopy data suggest that MxB attacked the fivefold symmetry axes as the <italic>punched capsids</italic> had dramatic dents on the capsid vertices. MxB might furthermore attack the portal cap, a cap of HSV1-pUL25 or its homologs in other herpesviruses, which seals the pUL6 portal after DNA packaging is completed (<xref ref-type="bibr" rid="bib61">Liu et al., 2019</xref>, <xref ref-type="bibr" rid="bib64">McElwee et al., 2018</xref>; <xref ref-type="bibr" rid="bib67">Naniima et al., 2021</xref>). The high internal capsid pressure due to the negatively charged genome (<xref ref-type="bibr" rid="bib5">Bauer et al., 2013</xref>; <xref ref-type="bibr" rid="bib77">Roos et al., 2009</xref>) could support the MxB attack from the outside. The limited trypsin treatment might have primed the D capsids for disassembly, as they contained less pUL36, pUL17, pUL25, and pUL6 than the V capsids. However, MxB also attacked V<sub>0.5</sub> capsids that resemble cytosolic capsids during nuclear targeting or after nuclear egress (<xref ref-type="bibr" rid="bib69">Ojala et al., 2000</xref>; <xref ref-type="bibr" rid="bib100">Wolfstein et al., 2006</xref>; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib2">Anderson et al., 2014</xref>); just not as fast, and not as efficient. Altogether, these results suggest that increasing tegumentation protects incoming and newly assembled capsids, possibly by masking the MxB target structure, or by inhibiting its GTPase cycle.</p><p>The MxB-mediated capsid disassembly required its NTE(1-25), GTP hydrolysis, and dimerization. For the homologous MxA GTPase that limits infection of many RNA viruses (<xref ref-type="bibr" rid="bib39">Haller et al., 2015</xref>), <xref ref-type="bibr" rid="bib34">Gao et al., 2011</xref> proposed a restriction mechanism that involves GTP hydrolysis and a mechano-chemical coupling within ring-like oligomers with the GTPase domains being exposed on their outer diameter (<xref ref-type="bibr" rid="bib34">Gao et al., 2011</xref>). Similarly, MxB can also assemble into helical tubes with the NTE and the GTPase domain oriented outwards (<xref ref-type="bibr" rid="bib1">Alvarez et al., 2017</xref>). Accordingly, MxB monomers and dimers might associate with the capsid vertices and insert between the hexons of neighboring capsid faces. A further oligomerization of MxB and/or conformational changes associated with GTP hydrolysis might then exert destabilizing forces onto the capsid shells, and ultimately push the capsid faces apart.</p></sec><sec id="s3-4"><title>Does MxB induce capsid disassembly in cells?</title><p>Future studies need to investigate whether MxB also induces the disassembly of herpesviral capsids in cells. Upon docking of an incoming capsid to a NPC, the pUL25 portal cap is supposed to be displaced, the pUL6 portal to be opened, and the DNA to be ejected from the capsid into the nucleoplasm due to this intramolecular repulsion (<xref ref-type="bibr" rid="bib10">Brandariz-Nuñez et al., 2019</xref>; <xref ref-type="bibr" rid="bib28">Döhner et al., 2021</xref>; <xref ref-type="bibr" rid="bib69">Ojala et al., 2000</xref>; <xref ref-type="bibr" rid="bib75">Rode et al., 2011</xref>). In uninfected cells, there is a low amount of constitutively expressed MxB localized at the NPCs (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>; <xref ref-type="bibr" rid="bib51">Kane et al., 2018</xref>; <xref ref-type="bibr" rid="bib66">Melén and Julkunen, 1997</xref>), which might dislodge the portal cap and open the capsid portal on the incoming capsid to release the incoming genome into the nucleoplasm.</p><p>Crameri et al., proposed that the higher amounts of IFN-induced MxB may block cytosolic capsid transport, genome uncoating at the NPCs, and/or the release of viral genomes into the nucleoplasm, which is consistent with our biochemical data demonstrating MxB binding to HSV-1 capsids (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>). MxB-mediated disassembly of capsids that we report here would further reduce capsid targeting to the NPCs and genome release into the nucleoplasm. Accordingly, there are fewer HSV-1 capsid puncta in MxB expressing cells (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>). Consistent with our data on capsid disassembly with MxB(26-715), MxB(K131A), or MxB(M574D), restricting the infection of HSV-1, MCMV, and MHV68 also requires the NTE, GTP hydrolysis, and dimerization of MxB (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>). Restriction of HIV infection depends also on MxB NTE and on MxB dimerization, while the role of its GTPase function requires further investigation (<xref ref-type="bibr" rid="bib11">Buffone et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Fricke et al., 2014</xref>; <xref ref-type="bibr" rid="bib37">Goujon et al., 2014</xref>; <xref ref-type="bibr" rid="bib84">Schulte et al., 2015</xref>; <xref ref-type="bibr" rid="bib101">Xie et al., 2021</xref>). It will be interesting to determine whether MxB only competes for the binding of host factors required for HIV intracellular trafficking, such as microtubule motor adaptors (BICD2; FEZ-1) or nucleoporins (reviewed in <xref ref-type="bibr" rid="bib92">Temple et al., 2020</xref>), or whether it also induces HIV capsid disassembly.</p><p>Our data together with Schilling et al., and Crameri et al., suggest that the IFN-inducible MxB restricts HSV-1, HSV-2, VZV, and possibly other herpesviruses, by promoting efficient capsid disassembly (<xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>). We cannot exclude that a surplus of capsid- and NPC-associated MxB imposes further restrictions on intracellular transport and genome release into the nucleoplasm. However, if MxB(1-715) would disassemble viral capsids before they are oriented properly with their portal toward the NPCs, their genomes would end up in the cytosol and would not be delivered into the nucleoplasm. There are fewer incoming cytoplasmic capsids in cells expressing MxB (<xref ref-type="bibr" rid="bib21">Crameri et al., 2018</xref>), and incoming VP5 is ubiquitinated and degraded by proteasomes in macrophages (<xref ref-type="bibr" rid="bib43">Horan et al., 2013</xref>; <xref ref-type="bibr" rid="bib90">Sun et al., 2019</xref>). Therefore, capsid disassembly intermediates might be degraded in cells, while we could characterize them in our biochemical cell-free assays in which proteases had been blocked.</p><p>The viral genomes exposed after MxB-induced capsid disassembly might be degraded by the DNase TREX1 (<xref ref-type="bibr" rid="bib90">Sun et al., 2019</xref>), or stimulate the DNA sensors AIM2, cGAS, or IFI16, and the induction of antiviral host mechanisms. As an inoculation with destabilized HIV-1 capsids leads to an increased activation of the DNA sensor cGAS (<xref ref-type="bibr" rid="bib89">Sumner et al., 2020</xref>), the IFN-induced increased MxB expression might lead to a similar outcome in cells infected with herpesviruses. Accordingly, MxB may not only restrict herpesviruses by capsid disassembly, but also increase the exposure of viral genomes to cytosolic DNA sensors, which in turn would induce an IFN response, inflammation as well as innate and adaptive immune responses. Thus, MxB could be the long sought-after capsid sensor that destroys the sturdy herpesvirus capsids, and possibly HIV cores and other viral capsids, to promote host viral genome sensing.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Cells</title><p>All cells were maintained in a humidified incubator at 37 °C with 5% CO<sub>2</sub>, passaged twice per week, and were tested negative for mycoplasma contamination. BHK-21 (ATCC CCL-10) and Vero cells (ATCC CCL-81) were cultured in MEM Eagle with 1% NEAA (Cytogen, Wetzlar, Germany) and 10% or 7.5% (v/v) FBS, respectively (Good Forte; PAN-Biotech, Aidenbach, Germany). HaCat (<xref ref-type="bibr" rid="bib9">Boukamp et al., 1988</xref>; kind gift from Detlef Neumann, Hannover Medical School, Hannover, Germany) and hTERT RPE-1 (RPE; CRL-2302, Clontech) were cultured in DMEM Gibco (Invitrogen) with 7.5% or 10% (v/v) FBS, respectively (Capricorn Scientific, Ebsdorfergrund, Germany). THP-1 cells (ATCC TIB-202; kind gift from Walther Mothes, Yale University, New Haven, USA) were cultured in RPMI Medium 1640 (Thermo Fisher Scientific, Waltham, Massachusetts, United States) with 10% FBS (Thermo Fisher Scientific, Waltham, Massachusetts, United States). THP-1 were stimulated with 100 nM phorbol 12-myristate 13-acetate (PMA; Sigma-Aldrich, Germany) for 48 hr and used immediately (Mφ) or after 3 days of rest (Mφ<sub>R</sub>). The cells were cultured with 1000 U/mL human type I IFN-α2a (Mφ<sub>IFN</sub>; R&amp;D Systems, Minneapolis, Minnesota, USA) or left untreated for 16 hr.</p><p>A549-derived cells (ATCC CCL-185) were cultured in DMEM with 10% FCS. In addition to A549 control cells, we used A549 cell lines stably expressing MxB(1-715), MxB(1–715/K131A), MxB(1–715/T151A), MxB(1–715/M574D), MxB(26-715), or MxA(1-662) upon transduction with the respective pLVX vectors with an engineered Kozak sequence to favor expression of the MxB(1-715) over the MxB(26-715) proteins (<xref ref-type="bibr" rid="bib81">Schilling et al., 2018</xref>). Furthermore, we generated A549-MxBFLAG cells expressing MxB(1-715)FLAG and MxB(26-715)FLAG, both tagged with the FLAG epitope (<named-content content-type="sequence">GACTACAAAGACGATGACGACAAG</named-content>) at the C-terminus of MxB (GenBAnk NM_002463), and A549-MxB(1-715)-MxB(26-715) cells expressing untagged MxB(1-715) and MxB(26-715) using the pLKOD-Ires-Puro vector (Clontech Takara Bio, Mountain View, United States). MeWo cells (kind gift from Graham Ogg; University of Oxford, Oxford, UK) were cultured in MEM with 10% FCS, NEAA, and 1 mM sodium pyruvate. None of the cells used in this study were identified in the list of commonly misidentified cell lines (International Cell Line Authentication Committee; <ext-link ext-link-type="uri" xlink:href="https://iclac.org">https://iclac.org</ext-link>).</p></sec><sec id="s4-2"><title>Viruses</title><p>Virus stocks of HSV-1(17<sup>+</sup>)Lox (<xref ref-type="bibr" rid="bib80">Sandbaumhüter et al., 2013</xref>), HSV-1 strain KOS (<xref ref-type="bibr" rid="bib97">Warner et al., 1998</xref>; kind gift from Pat Spear, Northwestern Medical School, Chicago, USA), and HSV-2 strain 333 (<xref ref-type="bibr" rid="bib97">Warner et al., 1998</xref>; kind gift from Helena Browne, Cambridge University, Cambridge, UK) were prepared as reported before (<xref ref-type="bibr" rid="bib26">Döhner et al., 2006</xref>, <xref ref-type="bibr" rid="bib38">Grosche et al., 2019</xref>). Extracellular particles were harvested from the supernatant of BHK-21 cells infected with 3–4 x 10<sup>4</sup> PFU/mL (MOI of 0.01 PFU/cell) for 2–3 days until the cells had detached from the culture flasks, and plaque-titrated on Vero cells. VZV rOka (kind gift from Jeffrey Cohen, NIH, Bethesda, US) was maintained in infected MeWo cells (<xref ref-type="bibr" rid="bib17">Cohen and Seidel, 1993</xref>; <xref ref-type="bibr" rid="bib42">Hertzog et al., 2020</xref>). After 2–4 days, the VZV-infected cells as indicated by cytopathic effects were harvested, mixed with naive MeWo cells at a ratio of 1:4 to 1:8 for continued culture. Aliquots of frozen infected cells were used to inoculate cultures used for capsid preparation.</p></sec><sec id="s4-3"><title>HSV-1 infection</title><p>THP-1 were seeded at 2.5 × 10<sup>5</sup> cells per six-well, treated with 100 nM PMA (Sigma-Aldrich, Germany) for 48 hr, and used immediately (Mφ) or after 3 days of rest (Mφ<sub>R</sub>). The cells were then induced with 1000 U/mL of IFN-α (Mφ<sub>IFN</sub>) or left untreated for 16 hr. On the next day, they were inoculated with HSV-1(17<sup>+</sup>)Lox at 2.5 × 10<sup>6</sup>, 2.5 × 10<sup>7</sup>, or 5 × 10<sup>7</sup> PFU/mL (MOI of 5, 50, or 100 respectively) in CO<sub>2</sub>-independent medium (Gibco Life Technologies) supplemented with 0.1% (w/v) cell culture grade fatty-acid-free bovine serum albumin (BSA; PAA Laboratories GmbH) for 30 min, and then shifted to regular culture medium at 37 °C and 5% CO<sub>2.</sub> At the indicated times, the cells and the corresponding media were harvested separately and snap-frozen in liquid nitrogen. These samples as well as and HSV-1 and HSV-2 inocula were titrated on Vero cells (<xref ref-type="bibr" rid="bib26">Döhner et al., 2006</xref>, <xref ref-type="bibr" rid="bib38">Grosche et al., 2019</xref>).</p></sec><sec id="s4-4"><title>Preparation of V<sub>0.1</sub>, V<sub>0.5</sub>, and V<sub>1</sub> and D capsids</title><p>Extracellular HSV-1 or HSV-2 particles were harvested by sedimentation at 12,000 rpm for 90 min at 4 °C (Type 19 rotor, Beckman-Coulter) from the medium of BHK-21 cells (40 × 175 cm² flasks; 2–2.5 x 10<sup>7</sup> cells/flask) infected with 0.01 PFU/cell (2–6.7 x 10<sup>4</sup> PFU/mL) for 2.5 days. The resulting medium pellets (MP) were resuspended in 2 mL of MKT buffer (20 mM MES, 30 mM Tris-HCl, 100 mM KCl, pH 7.4), treated with 0.5 mg/mL trypsin (Sigma-Aldrich, Germany) at 37 °C for 1 hr which was then inactivated with 5 mg/mL trypsin inhibitor from soybean (SBTI; Fluka, Switzerland) for 10 min on ice (<xref ref-type="bibr" rid="bib69">Ojala et al., 2000</xref>; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>; <xref ref-type="bibr" rid="bib100">Wolfstein et al., 2006</xref>. These samples were then mixed with an equal volume of 2-fold lysis buffer (2% TX-100, 20 mM MES, 30 mM Tris, pH 7.4, 20 mM DTT, 1 x protease inhibitor cocktail [PIs, Roche cOmplete] with 0.2 M, 1 M or 2 M KCl; <xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>). The samples were layered on top of 20% (w/v) sucrose cushions in 20 mM MES, 30 mM Tris, pH 7.4 with 10 mM DTT, PIs with the respective KCl concentration, and sedimented at 110,000 g for 20 min at 4 °C (TLA-120.2 rotor, Beckman-Coulter). The supernatants and the cushions containing solubilized viral envelope and tegument proteins were carefully removed. The pellets were resuspended in BRB80 (80 mM PIPES, pH 6.8, 12 mM MgCl<sub>2</sub>, 1 mM EGTA) with 10 mM DTT, PIs, 0.1 U/mL protease-free DNase I (Promega, USA), and 100 mg/mL protease-free RNase (Roth GmbH, Germany) for 1 hr at 37 °C and then overnight at 4 °C. The capsids were sedimented at 110,000 g for 15 min at 4 °C (TLA-120.2) and resuspended in capsid binding buffer (CBB: 5% [w/v] sucrose, 20 mM HEPES-KOH, pH 7.3, 80 mM K-acetate, 1 mM EGTA, 2 mM Mg-acetate, 10 mM DTT and PIs) by ultrasound tip sonication at 40 W for about 5 × 5 s on ice. Furthermore, we treated V<sub>0.1</sub> capsids for 40 min at 37 °C with 10 µg/mL trypsin in CBB lacking PIs to generate D capsids by limited digestion. After the addition of 5 mg/mL SBTI for 10 min on ice to block the trypsin activity, the D capsids were sedimented at 110,000 x g and 4 °C for 15 min (TLA-120.2), and resuspended in CBB with PIs.</p></sec><sec id="s4-5"><title>Preparation of nuclear A, B, and C capsids</title><p>HSV-1 nuclear capsids were prepared from 40 × 175 cm² flasks with BHK-21 cells infected with 0.01 PFU/cell (3–4 x 10<sup>4</sup> PFU/mL) for about 2.5 days (<xref ref-type="bibr" rid="bib2">Anderson et al., 2014</xref>; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>; <xref ref-type="bibr" rid="bib87">Snijder et al., 2017</xref>; <xref ref-type="bibr" rid="bib100">Wolfstein et al., 2006</xref>). VZV nuclear capsids were harvested from infected MeWo cells cultured in 5–10 x 175 cm<sup>2</sup> flasks at maximum syncytia formation but before cell lysis. The cells were harvested, resuspended in MKT buffer (20 mM MES, 30 mM Tris, pH 7.4, 100 mM KCl), snap-frozen, and stored at –80 °C. Nuclear A, B, and C capsids were separated by sedimentation at 50,000 x g and 4 °C for 80 min (SW40Ti, Beckman Coulter) on linear 20% to 50% sucrose gradients in TKE buffer 20 mM Tris, pH 7.5, 500 mM KCl, 1 mM EDTA; diluted in three volumes of TKE supplemented with 2 mM DTT and PIs (Roche cOmplete). The capsids were sedimented in BSA-coated centrifuge tubes at 110,000 g at 4 °C for 20 min (TLA-120.2), resuspended in BRB80 buffer supplemented with 100 mg/mL RNase (Roth, Germany), 0.1 U/mL DNase I (M6101, Promega, USA), 10 mM DTT, and PIs, sedimented again, and resuspended in CBB with PIs.</p></sec><sec id="s4-6"><title>Calibration of capsid concentration</title><p>To calibrate the amount of capsid equivalents (CAP<sub>eq</sub>) among different experiments, we compared all capsid preparations used in this study with a calibration curve generated from the same starting preparation. The capsids were suspended in sample buffer (1% [w/v] SDS, 50 mM Tris-HCl, pH 6.8, 1% [v/v] β-mercaptoethanol, 5% [v/v] glycerol, PIs [Roche cOmplete]), and adsorbed to nitrocellulose membranes (BioTrace, Pall Laboratory) using a 48-slot suction device (Bio-DOT-SF, Bio-Rad, Hercules, California, USA). The membranes were probed with a polyclonal rabbit serum raised against purified HSV-1 nuclear capsids (SY4563; <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>; <xref ref-type="bibr" rid="bib27">Döhner et al., 2018</xref>) followed by secondary antibodies conjugated to fluorescent infrared dyes (donkey-anti-rabbit IgG-IRDye1 800CW; <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>), and documented with an Infrared Imaging System (Odyssey, Image Studio Lite Quantification Software, LI-COR Biosciences, Lincoln, Nebraska, USA). MPs harvested from one 175 cm² flasks of BHK-21 cells infected with HSV-1 contained about 0.5–1 x 10<sup>9</sup> PFU/mL, and 0.75–1.5 x 10<sup>9</sup> CAP<sub>eq</sub>/mL. A nuclear HSV-1 capsid fraction prepared from one 175 cm² flask contained about 0.5–1 x 10<sup>7</sup> CAP<sub>eq</sub> of A capsids, 1–2 x 10<sup>7</sup> CAP<sub>eq</sub> of B capsids, and 0.5–0.75 x 10<sup>7</sup> CAP<sub>eq</sub> of C capsids, and a nuclear VZV fraction from one 175 cm² flasks of MeWo cells 2–4 x 10<sup>5</sup> CAP<sub>eq</sub> of A capsids, 0.5–1 x 10<sup>6</sup> CAP<sub>eq</sub> of B capsids, and 0.8–1.6 x 10<sup>7</sup> CAP<sub>eq</sub> of C capsids. Capsid-host protein complexes were assembled <italic>in-solution</italic> using 7.5 × 10<sup>8</sup> CAP<sub>eq</sub>/condition for MS and immunoblot experiments, and for the <italic>on-grid</italic> electron microscopy assay 2 × 10<sup>7</sup> CAP<sub>eq</sub>/condition were used.</p></sec><sec id="s4-7"><title>Preparation of cytosol</title><p>Cytosolic extracts were prepared as described before (<xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>), dialyzed (7 K MW cut-off cassettes; Slide-A-Lyzer, Thermo Scientific), snap-frozen and stored at –80 °C. Prior to their use, the cytosols were supplemented with 1 mM ATP, 1 mM GTP, 7 mM creatine phosphate, 5 mM DTT, and PIs (Roche cOmplete), and centrifuged at 130,000 g for 30 min at 4 °C (TLA-120.2). We added nocodazole to 25 µM to the cytosols, and left them either untreated (ATP/GTP<sup>high</sup>) or supplemented them with 10 U/mL apyrase (Sigma; ATP/GTP<sup>low</sup>) for 15 min at RT.</p></sec><sec id="s4-8"><title>Assembly of capsid-host protein complexes <italic>in-solution</italic></title><p>Capsids were resuspended in CBB and cytosol at a protein concentration of 0.2 mg/mL in an assay volume of 60 µL per sample on a rotating platform at 800 rpm for 1 hr at 37 °C (c.f. <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). The capsid-host protein complexes were sedimented through a 30% sucrose cushion at 110,000 g for 20 min at 4 °C (TLA-100, Beckman-Coulter), resuspended in CBB by ultrasound tip sonication at 40 W for about 5 × 5 s on ice, and analyzed by mass spectrometry, immunoblot, or electron microscopy (<xref ref-type="bibr" rid="bib74">Radtke et al., 2014</xref>).</p></sec><sec id="s4-9"><title>SDS-PAGE and immunoblot</title><p>The samples were lysed in Laemmli buffer (1% [w/v] SDS, 50 mM Tris-HCl, pH 6.8, 1% [v/v] β-mercaptoethanol, 5% [v/v] glycerol, bromophenol blue, PIs [Roche cOmplete]). The proteins were separated on linear 7.5% to 12% or 10% to 15% SDS-PAGE, transferred to methanol-activated PVDF membranes, probed with rabbit or murine primary antibodies (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) and secondary antibodies conjugated to fluorescent infrared dyes (anti-rabbit IgG-IRDye1 800CW; anti-mouse IgG-IRDye1 680RD; <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) and documented with an Infrared Imaging System (Odyssey, Image Studio Lite Quantification Software, LI-COR Biosciences, Lincoln, Nebraska, USA).</p></sec><sec id="s4-10"><title>Mass spectrometry sample preparation and measurement</title><p>Capsid-host protein complexes were analyzed by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) in four independent biological replicates. The samples were resuspended in hot Laemmli buffer and separated in NuPAGE 4% to 12% Bis-Tris protein gels (Invitrogen) before <italic>in-</italic>gel digestion. Briefly, proteins were fixed and stained by Coomassie solution (0.4% G250, 30% methanol, 10% acetic acid). Sample lanes were excised, destained (50% ethanol, 25 mM ammonium bi-carbonate), dehydrated with 100% ethanol and dried using a SpeedVac centrifuge (Eppendorf, Concentrator plus). Gel pieces were rehydrated in trypsin solution (1/50 [w/w] trypsin/protein) overnight at 37 °C. Tryptic peptides were extracted in extraction buffer (3% trifluoroacetic acid, 30% acetonitrile), dried using a SpeedVac centrifuge, resuspended in 2 M Tris-HCl buffer before reduction and alkylation using 10 mM Tris(2-carboxyethyl)phosphine, 40 mM 2-Chloroacetamide in 25 mM Tris-HCl pH 8.5. The peptides were purified, concentrated on StageTips with three C18 Empore filter discs (3 M), separated on a liquid chromatography instrument, and analyzed by mass spectrometry (EASY- nLC 1200 system on an LTQ-Orbitrap XL; Thermo Fisher Scientific) as described before (<xref ref-type="bibr" rid="bib46">Hubel et al., 2019</xref>). Peptides were loaded on a 20 cm reverse-phase analytical column (75 μm column diameter; ReproSil-Pur C18-AQ 1.9 μm resin; Dr. Maisch) and separated using a 120 min acetonitrile gradient. The mass spectrometer was operated in Data-Dependent Analysis mode (DDA, XCalibur software v.3.0, Thermo Fisher).</p></sec><sec id="s4-11"><title>Mass-spectrometry data analysis</title><p>Raw files were processed with MaxQuant using iBAQ quantification and Match Between Runs option, and the protein groups were filtered with Perseus for reverse identification, modification site only identification, and MaxQuant contaminant list (<ext-link ext-link-type="uri" xlink:href="https://maxquant.net/maxquant/">https://maxquant.net/maxquant/</ext-link>, v1.6.2.10; <ext-link ext-link-type="uri" xlink:href="https://maxquant.net/perseus/">https://maxquant.net/perseus/</ext-link>, v1.6.5.0; <xref ref-type="bibr" rid="bib20">Cox and Mann, 2008</xref>; <xref ref-type="bibr" rid="bib95">Tyanova et al., 2016a</xref>; <xref ref-type="bibr" rid="bib96">Tyanova et al., 2016b</xref>). The iBAQ intensities were normalized across all samples to the overall median intensity of the HSV-1 capsid protein VP5. Cytosol and beads incubated with cytosol samples were normalized to all proteins detected in at least three replicates in each condition. Significant differences between given conditions were determined by a two-sided Welch t-test on protein groups present in three replicates of at least one condition, followed by permutation-based FDR statistics (250 permutations), using an absolute log<sub>2</sub> difference cut-off of 1 and an FDR cut-off of 0.05. To characterize the IFN induction, we annotated proteins reported as being induced by IFN type-I as <italic>ISGs</italic> proteins (InterferomeDB, &gt; 2 x change; <ext-link ext-link-type="uri" xlink:href="http://www.interferome.org/interferome/home.jspx">http://www.interferome.org/interferome/home.jspx</ext-link>; <xref ref-type="bibr" rid="bib78">Rusinova et al., 2013</xref>). We used the Fisher’s exact test against <italic>ISGs</italic> proteins as well as all Gene Ontology terms (GO; <xref ref-type="bibr" rid="bib4">Ashburner et al., 2000</xref>; <xref ref-type="bibr" rid="bib19">Consortium, 2021</xref>; <ext-link ext-link-type="uri" xlink:href="http://geneontology.org/">http://geneontology.org/</ext-link>) for enrichment analysis of proteins upregulated in IFN-induced Mφ<sub>IFN</sub> cytosol over Mφ<sub>R</sub> cytosol (log<sub>2</sub> difference ≥1.5; permutation-based FDR ≤ 0.05). The data were summarized in volcano or bar plots (GraphPad Prism v5.0, <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link>; Perseus v1.6.5.0; <xref ref-type="bibr" rid="bib96">Tyanova et al., 2016b</xref>).</p></sec><sec id="s4-12"><title>Interaction network assembly</title><p>We focused our analysis on proteins that showed specific differences from one capsid preparation to the other, within the same cytosol preparation, and considered host proteins with an enrichment higher than 1.5 log<sub>2</sub> fold changes and a permutation-based FDR ≤ 0.01 as specifically enriched. To visualize enrichment among different capsid-host protein complexes, we generated integrative networks using Cytoscape (<ext-link ext-link-type="uri" xlink:href="http://www.cytoscape.org/">http://www.cytoscape.org/</ext-link>; v3.7.2; <xref ref-type="bibr" rid="bib85">Shannon et al., 2003</xref>) and STRING (confidence score: 0.7; <xref ref-type="bibr" rid="bib91">Szklarczyk et al., 2019</xref>). STRING uses a combination of databases on co-expression, conserved occurrences, GO terms and Kyoto Encyclopedia of Genes and Genomes (KEGG; <ext-link ext-link-type="uri" xlink:href="https://www.genome.jp/kegg/">https://www.genome.jp/kegg/</ext-link>; <xref ref-type="bibr" rid="bib52">Kanehisa and Goto, 2000</xref>; <xref ref-type="bibr" rid="bib53">Kanehisa, 2019</xref>; <xref ref-type="bibr" rid="bib54">Kanehisa et al., 2021</xref>). To assemble pathway enrichments, we used DAVID, a Database for Annotation, Visualization and Integrated Discovery (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/home.jsp">https://david.ncifcrf.gov/home.jsp</ext-link>; v6.8; <xref ref-type="bibr" rid="bib44">Huang et al., 2009a</xref>; <xref ref-type="bibr" rid="bib45">Huang et al., 2009b</xref>) and the Cytoscape plug-ins ClueGO and CluePedia (<ext-link ext-link-type="uri" xlink:href="http://apps.cytoscape.org/apps/cluego">http://apps.cytoscape.org/apps/cluego</ext-link>, v2.5.7; <ext-link ext-link-type="uri" xlink:href="http://apps.cytoscape.org/apps/cluepedia">http://apps.cytoscape.org/apps/cluepedia</ext-link>, v1.5.7; <xref ref-type="bibr" rid="bib7">Bindea et al., 2009</xref>; <xref ref-type="bibr" rid="bib8">Bindea et al., 2013</xref>).</p></sec><sec id="s4-13"><title>Electron microscopy</title><p>Capsid-host protein complexes were assembled at ATP/GTP<sup>high</sup> in solution, harvested by ultracentrifugation, resuspended in CBB, and adsorbed onto enhanced hydrophilicity-400 mesh formvar- and carbon-coated copper grids (Stork Veco, The Netherlands; <xref ref-type="bibr" rid="bib73">Radtke et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Roos et al., 2009</xref>). Moreover, capsids at a concentration of 1 × 10<sup>7</sup> CAP<sub>eq</sub>/mL were adsorbed directly for 20 min at RT onto the grids. The grids were incubated on a 10 µL drop of cytosol with a protein concentration of 0.2 mg/mL and ATP/GTP<sup>high</sup> in a humid chamber for 1 hr at 37 °C. The samples were left untreated or labeled with anti-VP5 (pAb NC-1) and protein-A gold (10 nm diameter; Cell Microscopy Centre, Utrecht School of Medicine, The Netherlands). For both protocols, the grids were washed with PBS and ddH<sub>2</sub>O, contrasted with 2% uranyl acetate at pH 4.4, air dried, and analyzed by transmission electron microscopy (Morgani or Tecnai; FEI, Einthoven, The Netherlands). The capsid morphology was evaluated for about 100 structures/assay from about 15 randomly selected images of 2.7 µm² of three biological replicates. We classified capsomer-containing structures as <italic>punched</italic>, if they lacked one or more of their vertices but still had an icosahedral shape, and as <italic>flat shells</italic>, if they lacked the icosahedral shape but contained capsomers, and scored them as one capsid equivalent structure if they contained more than 100 capsomers.</p></sec><sec id="s4-14"><title>Capsid DNA uncoating assay</title><p>D capsids were incubated with cytosols from A549-control, A549-MxB(1-715), A549-MxB(M574D), or A549-MxB-FLAG for 1 hr at 37 °C or treated for 5 min with 1% SDS followed by 10 min with 10% TX-100 (<xref ref-type="bibr" rid="bib69">Ojala et al., 2000</xref>). The viral genomes released during the assay were degraded by adding 50 U/mL of benzonase for 1 hr at 37 °C, and the remaining protected DNA was purified with the DNA Blood Mini Kit (Qiagen, Hilden, Germany) and quantified by real-time PCR on a qTower<sup>3</sup> (Analytik Jena, Jena, Germany). The SYBR Green assay was performed with the Luna Universal qPCR Master Mix (NEB, Ipswich, MA, USA) according to the manufacturer’s instructions with primers specific for HSV-1 gB (UL27 gene) (HSV1_2 SYBR fwd: 5’-<named-content content-type="sequence">gtagccgtaaaacggggaca</named-content>-3’ and HSV1_2 SYBR rev: 5’-<named-content content-type="sequence">ccgacctcaagtacaacccc</named-content>-3’; <xref ref-type="bibr" rid="bib29">Engelmann et al., 2008</xref>). Standards and samples were run in triplicates and results expressed as % released viral DNA with the SDS/Tx-100 treatment normalized to 100%.</p></sec><sec id="s4-15"><title>Quantification and statistical analyses</title><p>We performed Welch’s t-testing, Kruskal-Wallis H-testing, Friedman and one-way analyses of variance with a Dunns or Bonferroni post-testing (GraphPad Prism v5.0; <ext-link ext-link-type="uri" xlink:href="https://www.graphpad.com/">https://www.graphpad.com/</ext-link>).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing - original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Data curation, Methodology, Resources, Validation, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis, Methodology, Software, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Methodology, Software, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Investigation, Methodology, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Data curation, Investigation, Methodology, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Data curation, Investigation, Methodology, Resources</p></fn><fn fn-type="con" id="con11"><p>Investigation, Methodology, Resources, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Methodology, Resources</p></fn><fn fn-type="con" id="con13"><p>Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con15"><p>Conceptualization, Funding acquisition, Methodology, Resources, Software, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con16"><p>Conceptualization, Funding acquisition, Methodology, Project administration, Resources, Software, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con18"><p>Conceptualization, Formal analysis, Funding acquisition, Investigation, Project administration, Resources, Supervision, Writing - original draft, Writing – review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Host proteins in THP-1 cytosols.</title><p>Intensity-Based Absolute Quantitation (iBAQ) counts of the host proteins identified in the proteomic analysis of the cytosolic extracts prepared from rested or IFN-induced THP-1 φ cytosol. Statistical analyses were performed with a Welch’s t-test. The following cut-offs were set for differentially-expressed proteins: permutation-based false-discovery rate (FDR) ≤ 0.05 and |log<sub>2</sub> fold-change| ≥ 1.5. The protein groups were filtered to keep only the intensities measured in at least three out of four replicates per condition. Gene Ontology knowledge was used to reference the proteins previously described as induced by interferon.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76804-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Host proteins in capsid-host protein complexes.</title><p>Intensity-Based Absolute Quantitation (iBAQ) counts of host proteins identified in the V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub> and D capsid-host protein complexes assembled in rested or IFN-induced THP-1 φ cytosol. Statistical analyses were performed with a Welch’s t-test. The following cut-offs were set for differentially bound proteins: permutation-based false-discovery rate (FDR) ≤ 0.05 and a |log<sub>2</sub> fold-change ≥1.5|. The protein groups were filtered to keep only those with intensities measured in at least three out of four replicates, in at least one condition. “Interaction significance” column indicates the proteins considered as specific interactors.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76804-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Viral proteins in capsid-host protein complexes.</title><p>Intensity-based absolute quantification (iBAQ) counts of HSV-1(17<sup>+</sup>)Lox viral proteins from isolated V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub> and D capsids (A) normalized to the intensity of the major capsid protein VP5, (B) unnormalized LFQ intensities. The viral proteins were filtered to keep only those with intensities measured in at least three out of four replicates, in at least one condition.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-76804-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>List of Antibodies.</title><p>mAb: monoclonal antibody. pAb: polyclonal antibody.Anti-capsid SY4563 (<xref ref-type="bibr" rid="bib27">Döhner et al., 2018</xref>); Anti-VP5 NC-1 (<xref ref-type="bibr" rid="bib16">Cohen et al., 1980</xref>); anti-calnexin (<xref ref-type="bibr" rid="bib40">Hammond and Helenius, 1994</xref>); Anti-MxA/MxB M143 (<xref ref-type="bibr" rid="bib31">Flohr et al., 1999</xref>).</p></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-76804-supp4-v2.docx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-76804-transrepform1-v2.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>The raw datasets produced in this study are available at PRIDE (PXD028276; <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pride">http://www.ebi.ac.uk/pride</ext-link>). The dataset analyses and the raw bottling images are included in the Supplementary Files 1-3 and in the Source Data folder, respectively.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Serrero</surname><given-names>MC</given-names></name><name><surname>Girault</surname><given-names>V</given-names></name><name><surname>Pichlmair</surname><given-names>A</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>The interferon-inducible antiviral GTPase MxB promotes capsid disassembly and genome release of herpesviruses</data-title><source>PRIDE</source><pub-id pub-id-type="accession" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD028276">PXD028276</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank Katinka Döhner and Franziska Hüsers (Institute of Virology, Hannover Medical School) as well as Miriam Schilling (University of Oxford, UK) for many constructive discussions and feedback on the manuscript, and Jasper Götting (Institute of Virology, Hannover Medical School) for support on bioinformatics analyses. We are grateful to Ari Helenius (ETH Zürich, Switzerland), Graham Ogg (University of Oxford, UK), Gary Cohen (University of Pennsylvania, USA), Helena Browne (Cambridge University, UK), Jay Brown (University of Virginia, USA), Jeffrey Cohen (NIH, Bethesda, USA), Pat Spear (Northwestern Medical School, USA), and Roselyn Eisenberg (University of Pennsylvania, USA) for their generous donation of virus strains and invaluable antibodies.</p><p>Our research was supported by the EU 7<sup>th</sup> framework (Marie-Curie Actions ITN-EDGE; <ext-link ext-link-type="uri" xlink:href="https://ec.europa.eu/research/mariecurieactions/about/innovative-training-networks_en">https://ec.europa.eu/research/mariecurieactions/about/innovative-training-networks_en</ext-link>, H2020-EU.1.3.1, #675,278 to JR, AP, and BS), the UK MRC (core funding of the Medical Research Council Human Immunology Unit, MC_UU_00008/8 to JR), the NIH (NIGMS, GM114141 to IMC), an EU ERC consolidator grant (ERC-CoG ProDAP 817798 to AP), the German Research Foundation (<ext-link ext-link-type="uri" xlink:href="http://www.dfg.de/">http://www.dfg.de/</ext-link>; PI1084/3, PI1084/4, PI1084/5, TRR179, and TRR237 to AP; KO1579/13 to GK; CRC900 C2 158989968, EXC62 REBIRTH 24102914, EXC2155 RESIST 390874280, SO403/6 to BS) and the Deutsches Zentrum für Infektionsforschung (DZIF) (TTU 07.826_00 to BS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarez</surname><given-names>FJD</given-names></name><name><surname>He</surname><given-names>S</given-names></name><name><surname>Perilla</surname><given-names>JR</given-names></name><name><surname>Jang</surname><given-names>S</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name><name><surname>Engelman</surname><given-names>AN</given-names></name><name><surname>Scheres</surname><given-names>SHW</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>CryoEM structure of MxB reveals a novel oligomerization interface critical for HIV restriction</article-title><source>Science Advances</source><volume>3</volume><elocation-id>e1701264</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1701264</pub-id><pub-id pub-id-type="pmid">28929138</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>F</given-names></name><name><surname>Savulescu</surname><given-names>AF</given-names></name><name><surname>Rudolph</surname><given-names>K</given-names></name><name><surname>Schipke</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>I</given-names></name><name><surname>Ibiricu</surname><given-names>I</given-names></name><name><surname>Rotem</surname><given-names>A</given-names></name><name><surname>Grünewald</surname><given-names>K</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Harel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Targeting of viral capsids to nuclear pores in a cell-free reconstitution system</article-title><source>Traffic</source><volume>15</volume><fpage>1266</fpage><lpage>1281</lpage><pub-id pub-id-type="doi">10.1111/tra.12209</pub-id><pub-id pub-id-type="pmid">25131140</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Arvin</surname><given-names>AM</given-names></name><name><surname>Abendroth</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><chapter-title>Varicella–Zoster Virus</chapter-title><person-group person-group-type="editor"><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Cohen</surname><given-names>JL</given-names></name><name><surname>Damania</surname><given-names>BA</given-names></name></person-group><source>Fields Virology: DNA Viruses</source><publisher-name>Wolters Kluwer Health/Lippincott Williams &amp; Wilkins</publisher-name><fpage>445</fpage><lpage>488</lpage></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashburner</surname><given-names>M</given-names></name><name><surname>Ball</surname><given-names>CA</given-names></name><name><surname>Blake</surname><given-names>JA</given-names></name><name><surname>Botstein</surname><given-names>D</given-names></name><name><surname>Butler</surname><given-names>H</given-names></name><name><surname>Cherry</surname><given-names>JM</given-names></name><name><surname>Davis</surname><given-names>AP</given-names></name><name><surname>Dolinski</surname><given-names>K</given-names></name><name><surname>Dwight</surname><given-names>SS</given-names></name><name><surname>Eppig</surname><given-names>JT</given-names></name><name><surname>Harris</surname><given-names>MA</given-names></name><name><surname>Hill</surname><given-names>DP</given-names></name><name><surname>Issel-Tarver</surname><given-names>L</given-names></name><name><surname>Kasarskis</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>S</given-names></name><name><surname>Matese</surname><given-names>JC</given-names></name><name><surname>Richardson</surname><given-names>JE</given-names></name><name><surname>Ringwald</surname><given-names>M</given-names></name><name><surname>Rubin</surname><given-names>GM</given-names></name><name><surname>Sherlock</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Gene Ontology: tool for the unification of biology</article-title><source>Nature Genetics</source><volume>25</volume><fpage>25</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1038/75556</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>DW</given-names></name><name><surname>Huffman</surname><given-names>JB</given-names></name><name><surname>Homa</surname><given-names>FL</given-names></name><name><surname>Evilevitch</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Herpes virus genome, the pressure is on</article-title><source>Journal of the American Chemical Society</source><volume>135</volume><fpage>11216</fpage><lpage>11221</lpage><pub-id pub-id-type="doi">10.1021/ja404008r</pub-id><pub-id pub-id-type="pmid">23829592</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betancor</surname><given-names>G</given-names></name><name><surname>Dicks</surname><given-names>MDJ</given-names></name><name><surname>Jimenez-Guardeño</surname><given-names>JM</given-names></name><name><surname>Ali</surname><given-names>NH</given-names></name><name><surname>Apolonia</surname><given-names>L</given-names></name><name><surname>Malim</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction</article-title><source>Cell Reports</source><volume>29</volume><fpage>1923</fpage><lpage>1933</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.10.009</pub-id><pub-id pub-id-type="pmid">31722207</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindea</surname><given-names>G</given-names></name><name><surname>Mlecnik</surname><given-names>B</given-names></name><name><surname>Hackl</surname><given-names>H</given-names></name><name><surname>Charoentong</surname><given-names>P</given-names></name><name><surname>Tosolini</surname><given-names>M</given-names></name><name><surname>Kirilovsky</surname><given-names>A</given-names></name><name><surname>Fridman</surname><given-names>WH</given-names></name><name><surname>Pagès</surname><given-names>F</given-names></name><name><surname>Trajanoski</surname><given-names>Z</given-names></name><name><surname>Galon</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks</article-title><source>Bioinformatics</source><volume>25</volume><fpage>1091</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp101</pub-id><pub-id pub-id-type="pmid">19237447</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bindea</surname><given-names>G</given-names></name><name><surname>Galon</surname><given-names>J</given-names></name><name><surname>Mlecnik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CluePedia Cytoscape plugin: pathway insights using integrated experimental and in silico data</article-title><source>Bioinformatics</source><volume>29</volume><fpage>661</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt019</pub-id><pub-id pub-id-type="pmid">23325622</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukamp</surname><given-names>P</given-names></name><name><surname>Petrussevska</surname><given-names>RT</given-names></name><name><surname>Breitkreutz</surname><given-names>D</given-names></name><name><surname>Hornung</surname><given-names>J</given-names></name><name><surname>Markham</surname><given-names>A</given-names></name><name><surname>Fusenig</surname><given-names>NE</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line</article-title><source>The Journal of Cell Biology</source><volume>106</volume><fpage>761</fpage><lpage>771</lpage><pub-id pub-id-type="doi">10.1083/jcb.106.3.761</pub-id><pub-id pub-id-type="pmid">2450098</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandariz-Nuñez</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Du</surname><given-names>T</given-names></name><name><surname>Evilevitch</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pressure-driven release of viral genome into a host nucleus is a mechanism leading to herpes infection</article-title><source>eLife</source><volume>8</volume><elocation-id>e47212</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.47212</pub-id><pub-id pub-id-type="pmid">31393262</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buffone</surname><given-names>C</given-names></name><name><surname>Schulte</surname><given-names>B</given-names></name><name><surname>Opp</surname><given-names>S</given-names></name><name><surname>Diaz-Griffero</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Contribution of MxB oligomerization to HIV-1 capsid binding and restriction</article-title><source>Journal of Virology</source><volume>89</volume><fpage>3285</fpage><lpage>3294</lpage><pub-id pub-id-type="doi">10.1128/JVI.03730-14</pub-id><pub-id pub-id-type="pmid">25568212</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrera</surname><given-names>JR</given-names></name><name><surname>Manivanh</surname><given-names>R</given-names></name><name><surname>North</surname><given-names>BJ</given-names></name><name><surname>Leib</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The ESCRT-Related ATPase Vps4 Is Modulated by Interferon during Herpes Simplex Virus 1 Infection</article-title><source>mBio</source><volume>10</volume><elocation-id>e02567-18</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02567-18</pub-id><pub-id pub-id-type="pmid">30837340</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>H</given-names></name><name><surname>Krueger</surname><given-names>EW</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Drizyte-Miller</surname><given-names>K</given-names></name><name><surname>Schulz</surname><given-names>ME</given-names></name><name><surname>McNiven</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The anti-viral dynamin family member MxB participates in mitochondrial integrity</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1048</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14727-w</pub-id><pub-id pub-id-type="pmid">32102993</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter-Timofte</surname><given-names>ME</given-names></name><name><surname>Paludan</surname><given-names>SR</given-names></name><name><surname>Mogensen</surname><given-names>TH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA Polymerase III as a Gatekeeper to Prevent Severe VZV Infections</article-title><source>Trends in Molecular Medicine</source><volume>24</volume><fpage>904</fpage><lpage>915</lpage><pub-id pub-id-type="doi">10.1016/j.molmed.2018.07.009</pub-id><pub-id pub-id-type="pmid">30115567</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Graf</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Kochs</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Conformational dynamics of dynamin-like MxA revealed by single-molecule FRET</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15744</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15744</pub-id><pub-id pub-id-type="pmid">28548099</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Ponce de Leon</surname><given-names>M</given-names></name><name><surname>Diggelmann</surname><given-names>H</given-names></name><name><surname>Lawrence</surname><given-names>WC</given-names></name><name><surname>Vernon</surname><given-names>SK</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2</article-title><source>Journal of Virology</source><volume>34</volume><fpage>521</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1128/JVI.34.2.521-531.1980</pub-id><pub-id pub-id-type="pmid">6154808</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>JI</given-names></name><name><surname>Seidel</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro</article-title><source>PNAS</source><volume>90</volume><fpage>7376</fpage><lpage>7380</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.15.7376</pub-id><pub-id pub-id-type="pmid">8394020</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coller</surname><given-names>KE</given-names></name><name><surname>Lee</surname><given-names>JI-H</given-names></name><name><surname>Ueda</surname><given-names>A</given-names></name><name><surname>Smith</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The capsid and tegument of the alphaherpesviruses are linked by an interaction between the UL25 and VP1/2 proteins</article-title><source>Journal of Virology</source><volume>81</volume><fpage>11790</fpage><lpage>11797</lpage><pub-id pub-id-type="doi">10.1128/JVI.01113-07</pub-id><pub-id pub-id-type="pmid">17715218</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Consortium</surname><given-names>GO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The Gene Ontology resource: enriching a GOld mine</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D325</fpage><lpage>D334</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1113</pub-id><pub-id pub-id-type="pmid">33290552</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id><pub-id pub-id-type="pmid">19029910</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crameri</surname><given-names>M</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Caduff</surname><given-names>N</given-names></name><name><surname>Walker</surname><given-names>R</given-names></name><name><surname>Steiner</surname><given-names>F</given-names></name><name><surname>Franzoso</surname><given-names>FD</given-names></name><name><surname>Gujer</surname><given-names>C</given-names></name><name><surname>Boucke</surname><given-names>K</given-names></name><name><surname>Kucera</surname><given-names>T</given-names></name><name><surname>Zbinden</surname><given-names>A</given-names></name><name><surname>Münz</surname><given-names>C</given-names></name><name><surname>Fraefel</surname><given-names>C</given-names></name><name><surname>Greber</surname><given-names>UF</given-names></name><name><surname>Pavlovic</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MxB is an interferon-induced restriction factor of human herpesviruses</article-title><source>Nature Communications</source><volume>9</volume><fpage>1980</fpage><lpage>1982</lpage><pub-id pub-id-type="doi">10.1038/s41467-018-04379-2</pub-id><pub-id pub-id-type="pmid">29773792</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crump</surname><given-names>CM</given-names></name><name><surname>Yates</surname><given-names>C</given-names></name><name><surname>Minson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4</article-title><source>Journal of Virology</source><volume>81</volume><fpage>7380</fpage><lpage>7387</lpage><pub-id pub-id-type="doi">10.1128/JVI.00222-07</pub-id><pub-id pub-id-type="pmid">17507493</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crump</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Virus Assembly and Egress of HSV</article-title><source>Advances in Experimental Medicine and Biology</source><volume>1045</volume><fpage>23</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/978-981-10-7230-7_2</pub-id><pub-id pub-id-type="pmid">29896661</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of the herpes simplex virus 1 capsid with associated tegument protein complexes</article-title><source>Science</source><volume>360</volume><elocation-id>eaao7298</elocation-id><pub-id pub-id-type="doi">10.1126/science.aao7298</pub-id><pub-id pub-id-type="pmid">29622628</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diefenbach</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Conserved tegument protein complexes: Essential components in the assembly of herpesviruses</article-title><source>Virus Research</source><volume>210</volume><fpage>308</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2015.09.007</pub-id><pub-id pub-id-type="pmid">26365681</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Radtke</surname><given-names>K</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Eclipse phase of herpes simplex virus type 1 infection: Efficient dynein-mediated capsid transport without the small capsid protein VP26</article-title><source>Journal of Virology</source><volume>80</volume><fpage>8211</fpage><lpage>8224</lpage><pub-id pub-id-type="doi">10.1128/JVI.02528-05</pub-id><pub-id pub-id-type="pmid">16873277</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Ramos-Nascimento</surname><given-names>A</given-names></name><name><surname>Bialy</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>F</given-names></name><name><surname>Hickford-Martinez</surname><given-names>A</given-names></name><name><surname>Rother</surname><given-names>F</given-names></name><name><surname>Koithan</surname><given-names>T</given-names></name><name><surname>Rudolph</surname><given-names>K</given-names></name><name><surname>Buch</surname><given-names>A</given-names></name><name><surname>Prank</surname><given-names>U</given-names></name><name><surname>Binz</surname><given-names>A</given-names></name><name><surname>Hügel</surname><given-names>S</given-names></name><name><surname>Lebbink</surname><given-names>RJ</given-names></name><name><surname>Hoeben</surname><given-names>RC</given-names></name><name><surname>Hartmann</surname><given-names>E</given-names></name><name><surname>Bader</surname><given-names>M</given-names></name><name><surname>Bauerfeind</surname><given-names>R</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Hutt-Fletcher</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Importin α1 is required for nuclear import of herpes simplex virus proteins and capsid assembly in fibroblasts and neurons</article-title><source>PLOS Pathogens</source><volume>14</volume><elocation-id>e1006823</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1006823</pub-id><pub-id pub-id-type="pmid">29304174</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Cornelius</surname><given-names>A</given-names></name><name><surname>Serrero</surname><given-names>MC</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Herpesvirus Capsids on Their Journey to the Center of the Cell</article-title><source>Current Opinion in Virology</source><volume>50</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2021.08.005</pub-id><pub-id pub-id-type="pmid">34464845</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engelmann</surname><given-names>I</given-names></name><name><surname>Petzold</surname><given-names>DR</given-names></name><name><surname>Kosinska</surname><given-names>A</given-names></name><name><surname>Hepkema</surname><given-names>BG</given-names></name><name><surname>Schulz</surname><given-names>TF</given-names></name><name><surname>Heim</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens</article-title><source>Journal of Medical Virology</source><volume>80</volume><fpage>467</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1002/jmv.21095</pub-id><pub-id pub-id-type="pmid">18205230</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everett</surname><given-names>RD</given-names></name><name><surname>Meredith</surname><given-names>M</given-names></name><name><surname>Orr</surname><given-names>A</given-names></name><name><surname>Cross</surname><given-names>A</given-names></name><name><surname>Kathoria</surname><given-names>M</given-names></name><name><surname>Parkinson</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to A herpesvirus regulatory protein</article-title><source>The EMBO Journal</source><volume>16</volume><fpage>566</fpage><lpage>577</lpage><pub-id pub-id-type="doi">10.1093/emboj/16.3.566</pub-id><pub-id pub-id-type="pmid">9034339</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flohr</surname><given-names>F</given-names></name><name><surname>Schneider-Schaulies</surname><given-names>S</given-names></name><name><surname>Haller</surname><given-names>O</given-names></name><name><surname>Kochs</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures</article-title><source>FEBS Letters</source><volume>463</volume><fpage>24</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/S0014-5793(99)01598-7</pub-id><pub-id pub-id-type="pmid">10601631</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fribourgh</surname><given-names>JL</given-names></name><name><surname>Nguyen</surname><given-names>HC</given-names></name><name><surname>Matreyek</surname><given-names>KA</given-names></name><name><surname>Alvarez</surname><given-names>FJD</given-names></name><name><surname>Summers</surname><given-names>BJ</given-names></name><name><surname>Dewdney</surname><given-names>TG</given-names></name><name><surname>Aiken</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Engelman</surname><given-names>A</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Structural insight into HIV-1 restriction by MxB</article-title><source>Cell Host &amp; Microbe</source><volume>16</volume><fpage>627</fpage><lpage>638</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2014.09.021</pub-id><pub-id pub-id-type="pmid">25312384</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fricke</surname><given-names>T</given-names></name><name><surname>White</surname><given-names>TE</given-names></name><name><surname>Schulte</surname><given-names>B</given-names></name><name><surname>de Souza Aranha Vieira</surname><given-names>DA</given-names></name><name><surname>Dharan</surname><given-names>A</given-names></name><name><surname>Campbell</surname><given-names>EM</given-names></name><name><surname>Brandariz-Nuñez</surname><given-names>A</given-names></name><name><surname>Diaz-Griffero</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1</article-title><source>Retrovirology</source><volume>11</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.1186/s12977-014-0068-x</pub-id><pub-id pub-id-type="pmid">25123063</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>von der Malsburg</surname><given-names>A</given-names></name><name><surname>Dick</surname><given-names>A</given-names></name><name><surname>Faelber</surname><given-names>K</given-names></name><name><surname>Schröder</surname><given-names>GF</given-names></name><name><surname>Haller</surname><given-names>O</given-names></name><name><surname>Kochs</surname><given-names>G</given-names></name><name><surname>Daumke</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function</article-title><source>Immunity</source><volume>35</volume><fpage>514</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.07.012</pub-id><pub-id pub-id-type="pmid">21962493</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gershon</surname><given-names>AA</given-names></name><name><surname>Breuer</surname><given-names>J</given-names></name><name><surname>Cohen</surname><given-names>JI</given-names></name><name><surname>Cohrs</surname><given-names>RJ</given-names></name><name><surname>Gershon</surname><given-names>MD</given-names></name><name><surname>Gilden</surname><given-names>D</given-names></name><name><surname>Grose</surname><given-names>C</given-names></name><name><surname>Hambleton</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>PGE</given-names></name><name><surname>Oxman</surname><given-names>MN</given-names></name><name><surname>Seward</surname><given-names>JF</given-names></name><name><surname>Yamanishi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Varicella zoster virus infection</article-title><source>Nature Reviews. Disease Primers</source><volume>1</volume><elocation-id>15016</elocation-id><pub-id pub-id-type="doi">10.1038/nrdp.2015.16</pub-id><pub-id pub-id-type="pmid">27188665</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goujon</surname><given-names>C</given-names></name><name><surname>Moncorgé</surname><given-names>O</given-names></name><name><surname>Bauby</surname><given-names>H</given-names></name><name><surname>Doyle</surname><given-names>T</given-names></name><name><surname>Ward</surname><given-names>CC</given-names></name><name><surname>Schaller</surname><given-names>T</given-names></name><name><surname>Hué</surname><given-names>S</given-names></name><name><surname>Barclay</surname><given-names>WS</given-names></name><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Malim</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection</article-title><source>Nature</source><volume>502</volume><fpage>559</fpage><lpage>562</lpage><pub-id pub-id-type="doi">10.1038/nature12542</pub-id><pub-id pub-id-type="pmid">24048477</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goujon</surname><given-names>C</given-names></name><name><surname>Moncorgé</surname><given-names>O</given-names></name><name><surname>Bauby</surname><given-names>H</given-names></name><name><surname>Doyle</surname><given-names>T</given-names></name><name><surname>Barclay</surname><given-names>WS</given-names></name><name><surname>Malim</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor</article-title><source>Journal of Virology</source><volume>88</volume><fpage>9017</fpage><lpage>9026</lpage><pub-id pub-id-type="doi">10.1128/JVI.01269-14</pub-id><pub-id pub-id-type="pmid">24899177</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosche</surname><given-names>L</given-names></name><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Düthorn</surname><given-names>A</given-names></name><name><surname>Hickford-Martinez</surname><given-names>A</given-names></name><name><surname>Steinkasserer</surname><given-names>A</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Herpes Simplex Virus Type 1 Propagation, Titration and Single-step Growth Curves</article-title><source>Bio-Protocol</source><volume>9</volume><elocation-id>e3441</elocation-id><pub-id pub-id-type="doi">10.21769/BioProtoc.3441</pub-id><pub-id pub-id-type="pmid">33654936</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haller</surname><given-names>O</given-names></name><name><surname>Staeheli</surname><given-names>P</given-names></name><name><surname>Schwemmle</surname><given-names>M</given-names></name><name><surname>Kochs</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Mx GTPases: dynamin-like antiviral machines of innate immunity</article-title><source>Trends in Microbiology</source><volume>23</volume><fpage>154</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/j.tim.2014.12.003</pub-id><pub-id pub-id-type="pmid">25572883</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hammond</surname><given-names>C</given-names></name><name><surname>Helenius</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus</article-title><source>The Journal of Cell Biology</source><volume>126</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1083/jcb.126.1.41</pub-id><pub-id pub-id-type="pmid">8027184</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hertzog</surname><given-names>J</given-names></name><name><surname>Rehwinkel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regulation and inhibition of the DNA sensor cGAS</article-title><source>EMBO Reports</source><volume>21</volume><elocation-id>e51345</elocation-id><pub-id pub-id-type="doi">10.15252/embr.202051345</pub-id><pub-id pub-id-type="pmid">33155371</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Hertzog</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Rigby</surname><given-names>RE</given-names></name><name><surname>Fowler</surname><given-names>G</given-names></name><name><surname>Cursi</surname><given-names>C</given-names></name><name><surname>Chauveau</surname><given-names>L</given-names></name><name><surname>Davenne</surname><given-names>T</given-names></name><name><surname>Kranzusch</surname><given-names>PJ</given-names></name><name><surname>Rehwinkel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Varicella-Zoster Virus ORF9 Is an Antagonist of the DNA Sensor CGAS</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.02.11.943415</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horan</surname><given-names>KA</given-names></name><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Jakobsen</surname><given-names>MR</given-names></name><name><surname>Holm</surname><given-names>CK</given-names></name><name><surname>Søby</surname><given-names>S</given-names></name><name><surname>Unterholzner</surname><given-names>L</given-names></name><name><surname>Thompson</surname><given-names>M</given-names></name><name><surname>West</surname><given-names>JA</given-names></name><name><surname>Iversen</surname><given-names>MB</given-names></name><name><surname>Rasmussen</surname><given-names>SB</given-names></name><name><surname>Ellermann-Eriksen</surname><given-names>S</given-names></name><name><surname>Kurt-Jones</surname><given-names>E</given-names></name><name><surname>Landolfo</surname><given-names>S</given-names></name><name><surname>Damania</surname><given-names>B</given-names></name><name><surname>Melchjorsen</surname><given-names>J</given-names></name><name><surname>Bowie</surname><given-names>AG</given-names></name><name><surname>Fitzgerald</surname><given-names>KA</given-names></name><name><surname>Paludan</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors</article-title><source>Journal of Immunology</source><volume>190</volume><fpage>2311</fpage><lpage>2319</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1202749</pub-id><pub-id pub-id-type="pmid">23345332</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009a</year><article-title>Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists</article-title><source>Nucleic Acids Research</source><volume>37</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id><pub-id pub-id-type="pmid">19033363</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009b</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hubel</surname><given-names>P</given-names></name><name><surname>Urban</surname><given-names>C</given-names></name><name><surname>Bergant</surname><given-names>V</given-names></name><name><surname>Schneider</surname><given-names>WM</given-names></name><name><surname>Knauer</surname><given-names>B</given-names></name><name><surname>Stukalov</surname><given-names>A</given-names></name><name><surname>Scaturro</surname><given-names>P</given-names></name><name><surname>Mann</surname><given-names>A</given-names></name><name><surname>Brunotte</surname><given-names>L</given-names></name><name><surname>Hoffmann</surname><given-names>HH</given-names></name><name><surname>Schoggins</surname><given-names>JW</given-names></name><name><surname>Schwemmle</surname><given-names>M</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name><name><surname>Pichlmair</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape</article-title><source>Nature Immunology</source><volume>20</volume><fpage>493</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0323-3</pub-id><pub-id pub-id-type="pmid">30833792</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huffmaster</surname><given-names>NJ</given-names></name><name><surname>Sollars</surname><given-names>PJ</given-names></name><name><surname>Richards</surname><given-names>AL</given-names></name><name><surname>Pickard</surname><given-names>GE</given-names></name><name><surname>Smith</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dynamic ubiquitination drives herpesvirus neuroinvasion</article-title><source>PNAS</source><volume>112</volume><fpage>12818</fpage><lpage>12823</lpage><pub-id pub-id-type="doi">10.1073/pnas.1512559112</pub-id><pub-id pub-id-type="pmid">26407585</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaguva Vasudevan</surname><given-names>AA</given-names></name><name><surname>Bähr</surname><given-names>A</given-names></name><name><surname>Grothmann</surname><given-names>R</given-names></name><name><surname>Singer</surname><given-names>A</given-names></name><name><surname>Häussinger</surname><given-names>D</given-names></name><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Münk</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>MXB inhibits murine cytomegalovirus</article-title><source>Virology</source><volume>522</volume><fpage>158</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2018.07.017</pub-id><pub-id pub-id-type="pmid">30032029</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Justice</surname><given-names>JL</given-names></name><name><surname>Kennedy</surname><given-names>MA</given-names></name><name><surname>Hutton</surname><given-names>JE</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Phelan</surname><given-names>B</given-names></name><name><surname>Cristea</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Systematic profiling of protein complex dynamics reveals DNA-PK phosphorylation of IFI16 en route to herpesvirus immunity</article-title><source>Science Advances</source><volume>7</volume><elocation-id>eabg6680</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abg6680</pub-id><pub-id pub-id-type="pmid">34144993</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname><given-names>M</given-names></name><name><surname>Yadav</surname><given-names>SS</given-names></name><name><surname>Bitzegeio</surname><given-names>J</given-names></name><name><surname>Kutluay</surname><given-names>SB</given-names></name><name><surname>Zang</surname><given-names>T</given-names></name><name><surname>Wilson</surname><given-names>SJ</given-names></name><name><surname>Schoggins</surname><given-names>JW</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Hatziioannou</surname><given-names>T</given-names></name><name><surname>Bieniasz</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>MX2 is an interferon-induced inhibitor of HIV-1 infection</article-title><source>Nature</source><volume>502</volume><fpage>563</fpage><lpage>566</lpage><pub-id pub-id-type="doi">10.1038/nature12653</pub-id><pub-id pub-id-type="pmid">24121441</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kane</surname><given-names>M</given-names></name><name><surname>Rebensburg</surname><given-names>SV</given-names></name><name><surname>Takata</surname><given-names>MA</given-names></name><name><surname>Zang</surname><given-names>TM</given-names></name><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Kvaratskhelia</surname><given-names>M</given-names></name><name><surname>Bieniasz</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2</article-title><source>eLife</source><volume>7</volume><elocation-id>e35738</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.35738</pub-id><pub-id pub-id-type="pmid">30084827</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Goto</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title><source>Nucleic Acids Research</source><volume>28</volume><fpage>27</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id><pub-id pub-id-type="pmid">10592173</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Toward understanding the origin and evolution of cellular organisms</article-title><source>Protein Science</source><volume>28</volume><fpage>1947</fpage><lpage>1951</lpage><pub-id pub-id-type="doi">10.1002/pro.3715</pub-id><pub-id pub-id-type="pmid">31441146</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Ishiguro-Watanabe</surname><given-names>M</given-names></name><name><surname>Tanabe</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>KEGG: integrating viruses and cellular organisms</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D545</fpage><lpage>D551</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa970</pub-id><pub-id pub-id-type="pmid">33125081</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>MC</given-names></name><name><surname>Raposo</surname><given-names>G</given-names></name><name><surname>Lemmon</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Inhibition of nuclear import and cell-cycle progression by mutated forms of the dynamin-like GTPase MxB</article-title><source>PNAS</source><volume>101</volume><fpage>8957</fpage><lpage>8962</lpage><pub-id pub-id-type="doi">10.1073/pnas.0403167101</pub-id><pub-id pub-id-type="pmid">15184662</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Heldwein</surname><given-names>EE</given-names></name><name><surname>Mohr</surname><given-names>IJ</given-names></name><name><surname>Sodroski</surname><given-names>CN</given-names></name></person-group><year iso-8601-date="2021">2021</year><chapter-title>Herpes Simplex Viruses: Mechanisms of Lytic and Latent Infection</chapter-title><person-group person-group-type="editor"><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Cohen</surname><given-names>JL</given-names></name><name><surname>Damania</surname><given-names>BA</given-names></name></person-group><source>Fields Virology: DNA Viruses</source><publisher-name>Wolters Kluwer Health/Lippincott Williams &amp; Wilkins</publisher-name><fpage>235</fpage><lpage>296</lpage></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name><surname>Orzalli</surname><given-names>MH</given-names></name><name><surname>Knipe</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Innate Immune Mechanisms and Herpes Simplex Virus Infection and Disease</article-title><source>Advances in Anatomy, Embryology, and Cell Biology</source><volume>223</volume><fpage>49</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/978-3-319-53168-7_3</pub-id><pub-id pub-id-type="pmid">28528439</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>SY</given-names></name><name><surname>Sanchez</surname><given-names>DJ</given-names></name><name><surname>Aliyari</surname><given-names>R</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Systematic identification of type I and type II interferon-induced antiviral factors</article-title><source>PNAS</source><volume>109</volume><fpage>4239</fpage><lpage>4244</lpage><pub-id pub-id-type="doi">10.1073/pnas.1114981109</pub-id><pub-id pub-id-type="pmid">22371602</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Pan</surname><given-names>Q</given-names></name><name><surname>Ding</surname><given-names>S</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>F</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Cen</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>F</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The interferon-inducible MxB protein inhibits HIV-1 infection</article-title><source>Cell Host &amp; Microbe</source><volume>14</volume><fpage>398</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.08.015</pub-id><pub-id pub-id-type="pmid">24055605</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YT</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Bohannon</surname><given-names>KP</given-names></name><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Gant Luxton</surname><given-names>GW</given-names></name><name><surname>Hui</surname><given-names>WH</given-names></name><name><surname>Bi</surname><given-names>GQ</given-names></name><name><surname>Smith</surname><given-names>GA</given-names></name><name><surname>Zhou</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A pUL25 dimer interfaces the pseudorabies virus capsid and tegument</article-title><source>The Journal of General Virology</source><volume>98</volume><fpage>2837</fpage><lpage>2849</lpage><pub-id pub-id-type="doi">10.1099/jgv.0.000903</pub-id><pub-id pub-id-type="pmid">29035172</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YT</given-names></name><name><surname>Jih</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>X</given-names></name><name><surname>Bi</surname><given-names>GQ</given-names></name><name><surname>Zhou</surname><given-names>ZH</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cryo-EM structures of herpes simplex virus type 1 portal vertex and packaged genome</article-title><source>Nature</source><volume>570</volume><fpage>257</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1248-6</pub-id><pub-id pub-id-type="pmid">31142842</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lum</surname><given-names>KK</given-names></name><name><surname>Cristea</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Host Innate Immune Response and Viral Immune Evasion During Alphaherpesvirus Infection</article-title><source>Current Issues in Molecular Biology</source><volume>42</volume><fpage>635</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.21775/cimb.042.635</pub-id><pub-id pub-id-type="pmid">33640867</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Ni</surname><given-names>G</given-names></name><name><surname>Damania</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Innate Sensing of DNA Virus Genomes</article-title><source>Annual Review of Virology</source><volume>5</volume><fpage>341</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1146/annurev-virology-092917-043244</pub-id><pub-id pub-id-type="pmid">30265633</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McElwee</surname><given-names>M</given-names></name><name><surname>Vijayakrishnan</surname><given-names>S</given-names></name><name><surname>Rixon</surname><given-names>F</given-names></name><name><surname>Bhella</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Structure of the herpes simplex virus portal-vertex</article-title><source>PLOS Biology</source><volume>16</volume><elocation-id>e2006191</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2006191</pub-id><pub-id pub-id-type="pmid">29924793</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melén</surname><given-names>K</given-names></name><name><surname>Keskinen</surname><given-names>P</given-names></name><name><surname>Ronni</surname><given-names>T</given-names></name><name><surname>Sareneva</surname><given-names>T</given-names></name><name><surname>Lounatmaa</surname><given-names>K</given-names></name><name><surname>Julkunen</surname><given-names>I</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Human MxB protein, an interferon-alpha-inducible GTPase, contains a nuclear targeting signal and is localized in the heterochromatin region beneath the nuclear envelope</article-title><source>The Journal of Biological Chemistry</source><volume>271</volume><fpage>23478</fpage><lpage>23486</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.38.23478</pub-id><pub-id pub-id-type="pmid">8798556</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Melén</surname><given-names>K</given-names></name><name><surname>Julkunen</surname><given-names>I</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Nuclear cotransport mechanism of cytoplasmic human MxB protein</article-title><source>The Journal of Biological Chemistry</source><volume>272</volume><fpage>32353</fpage><lpage>32359</lpage><pub-id pub-id-type="doi">10.1074/jbc.272.51.32353</pub-id><pub-id pub-id-type="pmid">9405443</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naniima</surname><given-names>P</given-names></name><name><surname>Naimo</surname><given-names>E</given-names></name><name><surname>Koch</surname><given-names>S</given-names></name><name><surname>Curth</surname><given-names>U</given-names></name><name><surname>Alkharsah</surname><given-names>KR</given-names></name><name><surname>Stroh</surname><given-names>LJ</given-names></name><name><surname>Binz</surname><given-names>A</given-names></name><name><surname>Beneke</surname><given-names>JM</given-names></name><name><surname>Vollmer</surname><given-names>B</given-names></name><name><surname>Boning</surname><given-names>H</given-names></name><name><surname>Borst</surname><given-names>EM</given-names></name><name><surname>Desai</surname><given-names>P</given-names></name><name><surname>Bohne</surname><given-names>J</given-names></name><name><surname>Messerle</surname><given-names>M</given-names></name><name><surname>Bauerfeind</surname><given-names>R</given-names></name><name><surname>Legrand</surname><given-names>P</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Schulz</surname><given-names>TF</given-names></name><name><surname>Krey</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Assembly of infectious Kaposi’s sarcoma-associated herpesvirus progeny requires formation of a pORF19 pentamer</article-title><source>PLOS Biology</source><volume>19</volume><elocation-id>e3001423</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3001423</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newcomb</surname><given-names>WW</given-names></name><name><surname>Brown</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Structure of the herpes simplex virus capsid: effects of extraction with guanidine hydrochloride and partial reconstitution of extracted capsids</article-title><source>Journal of Virology</source><volume>65</volume><fpage>613</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1128/jvi.65.2.613-620.1991</pub-id><pub-id pub-id-type="pmid">1846187</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojala</surname><given-names>PM</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Ebersold</surname><given-names>MW</given-names></name><name><surname>Kutay</surname><given-names>U</given-names></name><name><surname>Helenius</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Herpes Simplex Virus Type 1 Entry into Host Cells: Reconstitution of Capsid Binding and Uncoating at the Nuclear Pore Complex In Vitro</article-title><source>Molecular and Cellular Biology</source><volume>20</volume><fpage>4922</fpage><lpage>4931</lpage><pub-id pub-id-type="doi">10.1128/MCB.20.13.4922-4931.2000</pub-id><pub-id pub-id-type="pmid">10848617</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>HG</given-names></name><name><surname>Read</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Virion Host Shutoff Endonuclease (UL41) of Herpes Simplex Virus Interacts with the Cellular Cap-Binding Complex eIF4F</article-title><source>Journal of Virology</source><volume>84</volume><fpage>6886</fpage><lpage>6890</lpage><pub-id pub-id-type="doi">10.1128/JVI.00166-10</pub-id><pub-id pub-id-type="pmid">20427534</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paludan</surname><given-names>SR</given-names></name><name><surname>Reinert</surname><given-names>LS</given-names></name><name><surname>Hornung</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer</article-title><source>Nature Reviews Immunology</source><volume>19</volume><fpage>141</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0117-0</pub-id><pub-id pub-id-type="pmid">30644449</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilla</surname><given-names>C</given-names></name><name><surname>Emanuelli</surname><given-names>T</given-names></name><name><surname>Frassetto</surname><given-names>SS</given-names></name><name><surname>Battastini</surname><given-names>AM</given-names></name><name><surname>Dias</surname><given-names>RD</given-names></name><name><surname>Sarkis</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>ATP diphosphohydrolase activity (apyrase, EC 3.6.1.5) in human blood platelets</article-title><source>Platelets</source><volume>7</volume><fpage>225</fpage><lpage>230</lpage><pub-id pub-id-type="doi">10.3109/09537109609023582</pub-id><pub-id pub-id-type="pmid">21043691</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radtke</surname><given-names>K</given-names></name><name><surname>Kieneke</surname><given-names>D</given-names></name><name><surname>Wolfstein</surname><given-names>A</given-names></name><name><surname>Michael</surname><given-names>K</given-names></name><name><surname>Steffen</surname><given-names>W</given-names></name><name><surname>Scholz</surname><given-names>T</given-names></name><name><surname>Karger</surname><given-names>A</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Plus- and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures</article-title><source>PLOS Pathogens</source><volume>6</volume><elocation-id>e1000991</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000991</pub-id><pub-id pub-id-type="pmid">20628567</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radtke</surname><given-names>K</given-names></name><name><surname>Anderson</surname><given-names>F</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A precipitation-based assay to analyze interactions of viral particles with cytosolic host factors</article-title><source>Methods in Molecular Biology</source><volume>1144</volume><fpage>191</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0428-0_13</pub-id><pub-id pub-id-type="pmid">24671685</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rode</surname><given-names>K</given-names></name><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Binz</surname><given-names>A</given-names></name><name><surname>Glass</surname><given-names>M</given-names></name><name><surname>Strive</surname><given-names>T</given-names></name><name><surname>Bauerfeind</surname><given-names>R</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Uncoupling uncoating of herpes simplex virus genomes from their nuclear import and gene expression</article-title><source>Journal of Virology</source><volume>85</volume><fpage>4271</fpage><lpage>4283</lpage><pub-id pub-id-type="doi">10.1128/JVI.02067-10</pub-id><pub-id pub-id-type="pmid">21345968</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez</surname><given-names>MC</given-names></name><name><surname>Dybas</surname><given-names>JM</given-names></name><name><surname>Hughes</surname><given-names>J</given-names></name><name><surname>Weitzman</surname><given-names>MD</given-names></name><name><surname>Boutell</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The HSV-1 ubiquitin ligase ICP0: Modifying the cellular proteome to promote infection</article-title><source>Virus Research</source><volume>285</volume><elocation-id>198015</elocation-id><pub-id pub-id-type="doi">10.1016/j.virusres.2020.198015</pub-id><pub-id pub-id-type="pmid">32416261</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname><given-names>WH</given-names></name><name><surname>Radtke</surname><given-names>K</given-names></name><name><surname>Kniesmeijer</surname><given-names>E</given-names></name><name><surname>Geertsema</surname><given-names>H</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Wuite</surname><given-names>GJL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Scaffold expulsion and genome packaging trigger stabilization of herpes simplex virus capsids</article-title><source>PNAS</source><volume>106</volume><fpage>9673</fpage><lpage>9678</lpage><pub-id pub-id-type="doi">10.1073/pnas.0901514106</pub-id><pub-id pub-id-type="pmid">19487681</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rusinova</surname><given-names>I</given-names></name><name><surname>Forster</surname><given-names>S</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>Kannan</surname><given-names>A</given-names></name><name><surname>Masse</surname><given-names>M</given-names></name><name><surname>Cumming</surname><given-names>H</given-names></name><name><surname>Chapman</surname><given-names>R</given-names></name><name><surname>Hertzog</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Interferome v2.0: an updated database of annotated interferon-regulated genes</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>D1040</fpage><lpage>D1046</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1215</pub-id><pub-id pub-id-type="pmid">23203888</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sae-Ueng</surname><given-names>U</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Catalano</surname><given-names>CE</given-names></name><name><surname>Huffman</surname><given-names>JB</given-names></name><name><surname>Homa</surname><given-names>FL</given-names></name><name><surname>Evilevitch</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Major capsid reinforcement by a minor protein in herpesviruses and phage</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>9096</fpage><lpage>9107</lpage><pub-id pub-id-type="doi">10.1093/nar/gku634</pub-id><pub-id pub-id-type="pmid">25053840</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandbaumhüter</surname><given-names>M</given-names></name><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Schipke</surname><given-names>J</given-names></name><name><surname>Binz</surname><given-names>A</given-names></name><name><surname>Pohlmann</surname><given-names>A</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Bauerfeind</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cytosolic herpes simplex virus capsids not only require binding inner tegument protein pUL36 but also pUL37 for active transport prior to secondary envelopment</article-title><source>Cellular Microbiology</source><volume>15</volume><fpage>248</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1111/cmi.12075</pub-id><pub-id pub-id-type="pmid">23186167</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schilling</surname><given-names>M</given-names></name><name><surname>Bulli</surname><given-names>L</given-names></name><name><surname>Weigang</surname><given-names>S</given-names></name><name><surname>Graf</surname><given-names>L</given-names></name><name><surname>Naumann</surname><given-names>S</given-names></name><name><surname>Patzina</surname><given-names>C</given-names></name><name><surname>Wagner</surname><given-names>V</given-names></name><name><surname>Bauersfeld</surname><given-names>L</given-names></name><name><surname>Goujon</surname><given-names>C</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Halenius</surname><given-names>A</given-names></name><name><surname>Ruzsics</surname><given-names>Z</given-names></name><name><surname>Schaller</surname><given-names>T</given-names></name><name><surname>Kochs</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Human MxB Protein Is a Pan-herpesvirus Restriction Factor</article-title><source>Journal of Virology</source><volume>92</volume><elocation-id>e01056-18</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.01056-18</pub-id><pub-id pub-id-type="pmid">29950411</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schipke</surname><given-names>J</given-names></name><name><surname>Pohlmann</surname><given-names>A</given-names></name><name><surname>Diestel</surname><given-names>R</given-names></name><name><surname>Binz</surname><given-names>A</given-names></name><name><surname>Rudolph</surname><given-names>K</given-names></name><name><surname>Nagel</surname><given-names>CH</given-names></name><name><surname>Bauerfeind</surname><given-names>R</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The C terminus of the large tegument protein pUL36 contains multiple capsid binding sites that function differently during assembly and cell entry of herpes simplex virus</article-title><source>Journal of Virology</source><volume>86</volume><fpage>3682</fpage><lpage>3700</lpage><pub-id pub-id-type="doi">10.1128/JVI.06432-11</pub-id><pub-id pub-id-type="pmid">22258258</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>SM</given-names></name><name><surname>Lee</surname><given-names>BH</given-names></name><name><surname>Nicola</surname><given-names>AV</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Viral entry and the ubiquitin-proteasome system</article-title><source>Cellular Microbiology</source><volume>23</volume><elocation-id>e13276</elocation-id><pub-id pub-id-type="doi">10.1111/cmi.13276</pub-id><pub-id pub-id-type="pmid">33037857</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulte</surname><given-names>B</given-names></name><name><surname>Buffone</surname><given-names>C</given-names></name><name><surname>Opp</surname><given-names>S</given-names></name><name><surname>Di Nunzio</surname><given-names>F</given-names></name><name><surname>De Souza Aranha Vieira</surname><given-names>DA</given-names></name><name><surname>Brandariz-Nuñez</surname><given-names>A</given-names></name><name><surname>Diaz-Griffero</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Restriction of HIV-1 Requires the N-Terminal Region of MxB as a Capsid-Binding Motif but Not as a Nuclear Localization Signal</article-title><source>Journal of Virology</source><volume>89</volume><fpage>8599</fpage><lpage>8610</lpage><pub-id pub-id-type="doi">10.1128/JVI.00753-15</pub-id><pub-id pub-id-type="pmid">26063425</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shannon</surname><given-names>P</given-names></name><name><surname>Markiel</surname><given-names>A</given-names></name><name><surname>Ozier</surname><given-names>O</given-names></name><name><surname>Baliga</surname><given-names>NS</given-names></name><name><surname>Wang</surname><given-names>JT</given-names></name><name><surname>Ramage</surname><given-names>D</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><name><surname>Schwikowski</surname><given-names>B</given-names></name><name><surname>Ideker</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title><source>Genome Research</source><volume>13</volume><fpage>2498</fpage><lpage>2504</lpage><pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id><pub-id pub-id-type="pmid">14597658</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smaga</surname><given-names>SS</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Summers</surname><given-names>BJ</given-names></name><name><surname>Digianantonio</surname><given-names>KM</given-names></name><name><surname>Perilla</surname><given-names>JR</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MxB Restricts HIV-1 by Targeting the Tri-hexamer Interface of the Viral Capsid</article-title><source>Structure</source><volume>27</volume><fpage>1234</fpage><lpage>1245</lpage><pub-id pub-id-type="doi">10.1016/j.str.2019.04.015</pub-id><pub-id pub-id-type="pmid">31155311</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Snijder</surname><given-names>J</given-names></name><name><surname>Radtke</surname><given-names>K</given-names></name><name><surname>Anderson</surname><given-names>F</given-names></name><name><surname>Scholtes</surname><given-names>L</given-names></name><name><surname>Corradini</surname><given-names>E</given-names></name><name><surname>Baines</surname><given-names>J</given-names></name><name><surname>Heck</surname><given-names>AJR</given-names></name><name><surname>Wuite</surname><given-names>GJL</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Roos</surname><given-names>WH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Vertex-Specific Proteins pUL17 and pUL25 Mechanically Reinforce Herpes Simplex Virus Capsids</article-title><source>Journal of Virology</source><volume>91</volume><elocation-id>e00123-17</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.00123-17</pub-id><pub-id pub-id-type="pmid">28381566</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stempel</surname><given-names>M</given-names></name><name><surname>Chan</surname><given-names>B</given-names></name><name><surname>Brinkmann</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Coevolution pays off: Herpesviruses have the license to escape the DNA sensing pathway</article-title><source>Medical Microbiology and Immunology</source><volume>208</volume><fpage>495</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1007/s00430-019-00582-0</pub-id><pub-id pub-id-type="pmid">30805724</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumner</surname><given-names>RP</given-names></name><name><surname>Harrison</surname><given-names>L</given-names></name><name><surname>Touizer</surname><given-names>E</given-names></name><name><surname>Peacock</surname><given-names>TP</given-names></name><name><surname>Spencer</surname><given-names>M</given-names></name><name><surname>Zuliani-Alvarez</surname><given-names>L</given-names></name><name><surname>Towers</surname><given-names>GJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Disrupting HIV-1 capsid formation causes cGAS sensing of viral DNA</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e103958</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2019103958</pub-id><pub-id pub-id-type="pmid">32852081</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Luecke</surname><given-names>S</given-names></name><name><surname>Bodda</surname><given-names>C</given-names></name><name><surname>Jønsson</surname><given-names>KL</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B-C</given-names></name><name><surname>Jensen</surname><given-names>SB</given-names></name><name><surname>Nordentoft</surname><given-names>I</given-names></name><name><surname>Jensen</surname><given-names>JM</given-names></name><name><surname>Jakobsen</surname><given-names>MR</given-names></name><name><surname>Paludan</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cellular Requirements for Sensing and Elimination of Incoming HSV-1 DNA and Capsids</article-title><source>Journal of Interferon &amp; Cytokine Research</source><volume>39</volume><fpage>191</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1089/jir.2018.0141</pub-id><pub-id pub-id-type="pmid">30855198</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Lyon</surname><given-names>D</given-names></name><name><surname>Junge</surname><given-names>A</given-names></name><name><surname>Wyder</surname><given-names>S</given-names></name><name><surname>Huerta-Cepas</surname><given-names>J</given-names></name><name><surname>Simonovic</surname><given-names>M</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>Mering</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D607</fpage><lpage>D613</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id><pub-id pub-id-type="pmid">30476243</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temple</surname><given-names>J</given-names></name><name><surname>Tripler</surname><given-names>TN</given-names></name><name><surname>Shen</surname><given-names>Q</given-names></name><name><surname>Xiong</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A snapshot of HIV-1 capsid–host interactions</article-title><source>Current Research in Structural Biology</source><volume>2</volume><fpage>222</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1016/j.crstbi.2020.10.002</pub-id><pub-id pub-id-type="pmid">34113849</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>S</given-names></name><name><surname>Yamabe</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>Y</given-names></name><name><surname>Konno</surname><given-names>T</given-names></name><name><surname>Tada</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>Establishment and characterization of a human acute monocytic leukemia cell line (THP-1)</article-title><source>International Journal of Cancer</source><volume>26</volume><fpage>171</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1002/ijc.2910260208</pub-id><pub-id pub-id-type="pmid">6970727</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turan</surname><given-names>A</given-names></name><name><surname>Grosche</surname><given-names>L</given-names></name><name><surname>Krawczyk</surname><given-names>A</given-names></name><name><surname>Mühl-Zürbes</surname><given-names>P</given-names></name><name><surname>Drassner</surname><given-names>C</given-names></name><name><surname>Düthorn</surname><given-names>A</given-names></name><name><surname>Kummer</surname><given-names>M</given-names></name><name><surname>Hasenberg</surname><given-names>M</given-names></name><name><surname>Voortmann</surname><given-names>S</given-names></name><name><surname>Jastrow</surname><given-names>H</given-names></name><name><surname>Dörrie</surname><given-names>J</given-names></name><name><surname>Schaft</surname><given-names>N</given-names></name><name><surname>Kraner</surname><given-names>M</given-names></name><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name><name><surname>Steinkasserer</surname><given-names>A</given-names></name><name><surname>Heilingloh</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Autophagic degradation of lamins facilitates the nuclear egress of herpes simplex virus type 1</article-title><source>The Journal of Cell Biology</source><volume>218</volume><fpage>508</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1083/jcb.201801151</pub-id><pub-id pub-id-type="pmid">30587512</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyanova</surname><given-names>S</given-names></name><name><surname>Temu</surname><given-names>T</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>The MaxQuant computational platform for mass spectrometry-based shotgun proteomics</article-title><source>Nature Protocols</source><volume>11</volume><fpage>2301</fpage><lpage>2319</lpage><pub-id pub-id-type="doi">10.1038/nprot.2016.136</pub-id><pub-id pub-id-type="pmid">27809316</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyanova</surname><given-names>S</given-names></name><name><surname>Temu</surname><given-names>T</given-names></name><name><surname>Sinitcyn</surname><given-names>P</given-names></name><name><surname>Carlson</surname><given-names>A</given-names></name><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Geiger</surname><given-names>T</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>The Perseus computational platform for comprehensive analysis of (prote)omics data</article-title><source>Nature Methods</source><volume>13</volume><fpage>731</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3901</pub-id><pub-id pub-id-type="pmid">27348712</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>MS</given-names></name><name><surname>Geraghty</surname><given-names>RJ</given-names></name><name><surname>Martinez</surname><given-names>WM</given-names></name><name><surname>Montgomery</surname><given-names>RI</given-names></name><name><surname>Whitbeck</surname><given-names>JC</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Eisenberg</surname><given-names>RJ</given-names></name><name><surname>Cohen</surname><given-names>GH</given-names></name><name><surname>Spear</surname><given-names>PG</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus</article-title><source>Virology</source><volume>246</volume><fpage>179</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1006/viro.1998.9218</pub-id><pub-id pub-id-type="pmid">9657005</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Whitley</surname><given-names>R</given-names></name><name><surname>Roizman</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><chapter-title>Herpes Simplex Viruses</chapter-title><person-group person-group-type="editor"><name><surname>Richman</surname><given-names>DD</given-names></name><name><surname>Whitley</surname><given-names>RJ</given-names></name><name><surname>Hayden</surname><given-names>FJ</given-names></name></person-group><source>Clinical Virology, Fourth Edition</source><publisher-name>ASM Press</publisher-name><fpage>415</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1128/9781555819439</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Whitley</surname><given-names>R</given-names></name><name><surname>Johnston</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><chapter-title>Herpes Simplex Viruses: Pathogenesis and Clinical Insights</chapter-title><person-group person-group-type="editor"><name><surname>Howley</surname><given-names>PM</given-names></name><name><surname>Knipe</surname><given-names>DM</given-names></name><name><surname>Cohen</surname><given-names>JL</given-names></name><name><surname>Damania</surname><given-names>BA</given-names></name></person-group><source>In Fields Virology: DNA Viruses</source><publisher-name>Wolters Kluwer Health/Lippincott Williams &amp; Wilkins</publisher-name><fpage>297</fpage><lpage>323</lpage></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolfstein</surname><given-names>A</given-names></name><name><surname>Nagel</surname><given-names>CH</given-names></name><name><surname>Radtke</surname><given-names>K</given-names></name><name><surname>Döhner</surname><given-names>K</given-names></name><name><surname>Allan</surname><given-names>VJ</given-names></name><name><surname>Sodeik</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The inner tegument promotes herpes simplex virus capsid motility along microtubules in vitro</article-title><source>Traffic</source><volume>7</volume><fpage>227</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0854.2005.00379.x</pub-id><pub-id pub-id-type="pmid">16420530</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Ju</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Zan</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name><name><surname>Feng</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>GTPase Activity of MxB Contributes to Its Nuclear Location, Interaction with Nucleoporins and Anti-HIV-1 Activity</article-title><source>Virologica Sinica</source><volume>36</volume><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1007/s12250-020-00249-8</pub-id><pub-id pub-id-type="pmid">32632818</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zenner</surname><given-names>HL</given-names></name><name><surname>Yoshimura</surname><given-names>S-I</given-names></name><name><surname>Barr</surname><given-names>FA</given-names></name><name><surname>Crump</surname><given-names>CM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Analysis of Rab GTPase-activating proteins indicates that Rab1a/b and Rab43 are important for herpes simplex virus 1 secondary envelopment</article-title><source>Journal of Virology</source><volume>85</volume><fpage>8012</fpage><lpage>8021</lpage><pub-id pub-id-type="doi">10.1128/JVI.00500-11</pub-id><pub-id pub-id-type="pmid">21680502</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>McKnight</surname><given-names>JL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression</article-title><source>Journal of Virology</source><volume>67</volume><fpage>1482</fpage><lpage>1492</lpage><pub-id pub-id-type="doi">10.1128/JVI.67.3.1482-1492.1993</pub-id><pub-id pub-id-type="pmid">8382306</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Bao</surname><given-names>M</given-names></name><name><surname>Facchinetti</surname><given-names>V</given-names></name><name><surname>Jung</surname><given-names>SY</given-names></name><name><surname>Ghaffari</surname><given-names>AA</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>DDX1, DDX21, and DHX36 helicases form a complex with the adaptor molecule TRIF to sense dsRNA in dendritic cells</article-title><source>Immunity</source><volume>34</volume><fpage>866</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.03.027</pub-id><pub-id pub-id-type="pmid">21703541</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76804.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Geballe</surname><given-names>Adam P</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2022.01.25.477704" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.25.477704"/></front-stub><body><p>This paper uses an innovative cell-free protein-protein interaction system to identify factors that interact with HSV-1 capsids in infected cells. In addition to cataloging numerous capsid-interacting proteins, the manuscript probes the antiviral mechanism of one of these, MxB. The data provide strong support for an intriguing model in which MxB &quot;punches&quot; holes in HSV-1 capsids, releasing viral DNA and potentially triggering host DNA sensors. Moreover, the results suggest that viral proteins bind to and shield the capsids from MxB attack, offering a new perspective on how viruses might evade some host defenses.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76804.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Geballe</surname><given-names>Adam P</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/007ps6h72</institution-id><institution>Fred Hutchinson Cancer Research Center</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.01.25.477704">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.01.25.477704v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, one of whom is a member of our Board of Reviewing Editor, and the evaluation has been overseen by Päivi Ojala as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission. Both reviewers were impressed with the innovative experimental design, the extensive amount of data presented, and most importantly the new insights emerging from your experiments showing how MxB might function to inhibit HSV-1 and how HSV-1 might evade the MxB defense. The reviewers felt that parts of the manuscript need important clarifications but they do not feel additional experiments are necessary. Please address the concerns listed in the specific comments below.</p><p>Essential revisions:</p><p>1) The reviewers both ended up feeling that the initial studies cataloging the large amount of mass spectrometry data in the various samples did not logically lead to the very interesting in-depth focus of MxB. Can you explain more clearly your rationale for focusing on MxB from among all the factors identified?</p><p>2) The presentation and interpretation of the data in figure 8 should be clarified to address the concerns noted by reviewer 2.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>I just have a few suggestions on possible follow-up studies with regards to the mechanism of MxB's capsid destruction.</p><p>1. Would SDS-PAGE or Westerns with antibodies to capsid structural proteins at different stages during the MxB induced capsid degradation reveal if any of the capsid structural proteins are altered?</p><p>2. In the cell-free assay would any of the MxB extracts degrade another DNA virus capsid such as adenovirus, polyomavirus, or a phage capsid? This would be another way of showing that specific capsid surface proteins are required for MxB capsid interaction.</p><p>3. Figure S6. Would an MxB antibody label capsids in these immuno-gold EM studies?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The link between the first, proteomics part of the paper, and the second part, (MxB mechanism) seems tenuous. Unless I am missing it, I don't see MxB appearing in Figure S2C, Figure S3, Figure 3, or the supplementary tables. In Figure 2, MxB appears only to be slightly (insignificantly?) preferentially associated with D capsids. Can the author make a stronger rationale for linking the two parts of the paper? The proteomics data are potentially useful for future studies, but since the authors have not independently validated the findings (except by repetition), the presentation of them could be more succinct and possibly even more of the data (e.g., Figure 2) could be presented only as supplemental figures.</p><p>Line 265-268, Figure 7F. Did the authors test V[1.0] capsids? That analysis would be useful, especially since the results shown in Figure 7 and Figure 8 are not exactly consistent with each other and with the model they propose. Figure 8 shows that the viral proteins associated with the various V capsid preparations are quite similar to each other. But in Figure 7, it seems that V[0.5] capsids are more sensitive than V[0.1] capsids to damage by MxB.</p><p>Lines 292-293. The text describing the similarities and differences in proteins binding to the various capsid preparations does not fit well with the data in Figure 8. For example, V[0.1] capsids do not really contain substantially more pUL41, especially compared to V[1] capsids; V[0.1] capsids contain similar amounts of pUL40 as V[1] capsid, but much more than V[0.5] capsids; etc. Perhaps the author could focus on differences that are statistically different. These data do not identify any major proteins that show a gradient from low in D capsids to higher in [0.5] to highest in [0.1] capsids that would fit with the gradient of effects shown in Figure 7F. The discussion of these results should reflect the limitation of these results.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.76804.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The reviewers both ended up feeling that the initial studies cataloging the large amount of mass spectrometry data in the various samples did not logically lead to the very interesting in-depth focus of MxB. Can you explain more clearly your rationale for focusing on MxB from among all the factors identified?</p></disp-quote><p>We modified the text accordingly (c.f. response to reviewer 2, comment #1).</p><disp-quote content-type="editor-comment"><p>2) The presentation and interpretation of the data in figure 8 should be clarified to address the concerns noted by reviewer 2.</p></disp-quote><p>We modified the text accordingly (c.f. response to reviewer 2, comment #3).</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>I just have a few suggestions on possible follow-up studies with regards to the mechanism of MxB's capsid destruction.</p><p>1. Would SDS-PAGE or Westerns with antibodies to capsid structural proteins at different stages during the MxB induced capsid degradation reveal if any of the capsid structural proteins are altered?</p></disp-quote><p>Thank you for this suggestion. We agree that immunoblot analyses of time-course experiments on MxB induced capsid disassembly might detect consecutive dissociation of vertex-associated proteins such as the tegument proteins pUL36 and pUL37 as well as the capsid proteins pUL17 and pUL25. Although such experiments would be very informative, we agree that the required workload would exceed this revision.</p><p>Nevertheless, some considerations from our side. We are quite satisfied that we could transfer our experiments from analyzing sedimented capsids and capsid disassembly intermediates to the on-grid analyses (c.f. Figure 6A; Figure 7E, F, G).</p><p>To detect several of the structural HSV-1 proteins in one lane in an immunoblot, we required capsids derived from about 1 to 2 x 175 cm<sup>2</sup> cell culture flasks, for other HSV-1 proteins we would need even more. This is about 10 times as many capsids as for3 replicates in the on-grid EM assay (c.f. manuscript, lines 222-224). Thus, such immunoblot experiments are quite demanding in terms of working hours and consumables. Nevertheless, we plan to try the suggested experiments, either by immunoelectron microscopy or by SDS-PAGE.</p><p>Moreover, we treasure the “open-view” of the EM analysis. After we had discovered MxB-induced capsid disassembly, we became concerned whether disassembly intermediates might be less likely to sediment than intact capsids, and whether disassembly intermediates might be further damaged by ultracentrifugation and more importantly by the subsequent re-suspension.</p><disp-quote content-type="editor-comment"><p>2. In the cell-free assay would any of the MxB extracts degrade another DNA virus capsid such as adenovirus, polyomavirus, or a phage capsid? This would be another way of showing that specific capsid surface proteins are required for MxB capsid interaction.</p></disp-quote><p>Previous work from Georg Kochs et al. (Schilling et al. 2018) as well as Jovan Pavlovic et al. (Crameri et al. 2018) shows that MxB fails to restrict several RNA viruses, adenovirus Ad5, or vaccinia virus indicating that MxB shows antiviral activity against specific viruses.</p><p>Accordingly, we could not detect MxB binding to Ad5 capsids in our co-sedimentation assays (unpublished observations). In preliminary experiments with papillomavirus-like particles, we detected an MxB induced exposure of an internal epitope by immunoelectron microscopy (unpublished observations). Furthermore, we are expanding our studies to HCMV, MCMV and MHV68 capsids. While these experiments will be informative, we think that they require more work, and that they are beyond the scope of the present manuscript.</p><disp-quote content-type="editor-comment"><p>3. Figure S6. Would an MxB antibody label capsids in these immuno-gold EM studies?</p></disp-quote><p>Although such experiments would be informative, we think that they require more work, and that they are beyond the scope of the present manuscript.</p><p>So far, the commercially MxB antibodies that we tested did not label capsids treated with MxB cytosol in our immunoelectron microscopy trials. Therefore, we plan additional experiments with FLAG-tagged MxB and anti-FLAG antibodies.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The link between the first, proteomics part of the paper, and the second part, (MxB mechanism) seems tenuous. Can the author make a stronger rationale for linking the two parts of the paper?</p></disp-quote><p>In this study, we designed our cell-free capsid-host interaction assays (reviewed in Radtke <italic>et al.</italic> 2014) to identify IFN inducible proteins potentially restricting HSV-1 capsids, and therefore focused on proteins of the GO terms “<italic>Response to type I IFN”</italic> and “<italic>Regulation of type I IFN production”</italic> (c.f. Figure 4) binding to capsids.</p><p>To answer this comment, we have expanded the explanation for our rationale to focus on MxB (previous lines 179 – 183; in the revised manuscript lines 181 – 189):</p><p>“Particularly interesting was the discovery of MxB in these capsid-host protein complexes. MxB was significantly enriched on HSV-1 D capsids in Mφ<sub>IFN</sub> cytosol, and the IFN treatment had the strongest impact on the interaction of MxB with capsids. Moreover, the calculated enrichment score for MxB on capsids was very high although the MxB levels in the input cytosol were below the detection limit (undetected, Figure S2, Table S1). MxB but not its homolog MxA restricts infections of the herpesviruses HSV-1, HSV-2, MCMV, KSHV, and MHV-68, but its mode of action has not been elucidated (Crameri et al. 2018; Liu et al. 2012; Schilling et al. 2018; Vasudevan et al. 2018). For these reasons, we investigated the interaction of human MxB with HSV-1 capsids further.”</p><disp-quote content-type="editor-comment"><p>Unless I am missing it, I don't see MxB appearing in Figure S2C, Figure S3, Figure 3, or the supplementary tables. In Figure 2, MxB appears only to be slightly (insignificantly?) preferentially associated with D capsids.</p></disp-quote><p>In addition to line 85 of the introduction, we added to line 180: “…. were enriched for IFI16, OAS2, POLR1C, STAT2 and MxB (gene Mx2) in Mφ<sub>IFN</sub> but not in Mφ<sub>R</sub> (Figure 4, Figure S5).” to clearly indicate its protein name and its gene name.</p><p>Figure S2C reports on the changes in the protein composition of the cytosolic extracts upon IFN treatment. In these samples, the MxB induction was so low compared to the other IFN inducible proteins that it was not detected by mass spectrometry. In Figure S3B, MxB is listed under its gene name MX2 in bold in the 4<sup>th</sup> column as one protein of the 4<sup>th</sup> cluster; it is number 8 from the bottom of the top block of the 4<sup>th</sup> column. MxB is one of the many ISG proteins that we detected on the capsids, and that we indicated with the # symbol in this graph. In the supplementary tables, MxB is listed under its gene name MX2.</p><p>In Figure 2, we indicated in red those ISG proteins that were significantly enriched (permutation based FDR ≤ 0.05; log<sub>2</sub> difference ≥ 1.5) on either capsid type in these binary comparisons, and MxB enriched on D capsids in comparison to the 3 other viral capsid types.</p><p>In our functional enrichment analyses we used a conservative significance cutoff of an enrichment higher than 1.5 log<sub>2</sub> (2.83-fold change) and a permutation-based FDR ≤ 0.01 for the GO and the STRING analyses (Figure S4 and Figure 3). MxB did not reach these cut-offs and is therefore not represented in these graphs.</p><disp-quote content-type="editor-comment"><p>The proteomics data are potentially useful for future studies, but since the authors have not independently validated the findings (except by repetition), the presentation of them could be more succinct and possibly even more of the data (e.g., Figure 2) could be presented only as supplemental figures.</p></disp-quote><p>It is true that so far we have validated only the MxB interaction with capsids in depth. But Figure 2 provides a comparative overview on the complexity of the macrophage host protein-capsid complexes. We consider this dataset valuable and would prefer to present it without the need to consult supplementary figures and table.</p><p>Figure 2 shows that different protein sets bound to different viral capsids (0.1, 0.5 and 1 M) in comparison to the D capsids (compare A and B versus C as well as D and E versus F). As the tegumentation of the 0.1 M capsids was more complex, the set of associated host proteins was also more complex. Moreover, the capsids associate with other proteins in the IFN cytosol than in the control cytosol (compare left panels with respective right panels).</p><p>Therefore, we would like to keep Figure 2 among the main figures; also in light of comment 2.</p><disp-quote content-type="editor-comment"><p>Line 265-268, Figure 7F. Did the authors test V[1.0] capsids? That analysis would be useful, especially since the results shown in Figure 7 and Figure 8 are not exactly consistent with each other and with the model they propose. Figure 8 shows that the viral proteins associated with the various V capsid preparations are quite similar to each other. But in Figure 7, it seems that V[0.5] capsids are more sensitive than V[0.1] capsids to damage by MxB.</p></disp-quote><p>Unfortunately, we did not compare V[1.0] capsids in a time course disassembly experiment with V[0.5], V[0.1], or D capsids. We think that V[0.5] capsids are most similar to authentic cytosolic capsids, which unfortunately we cannot isolate in sufficient amounts for biochemical experiments.</p><p>V[0.5] capsids are the best substrates to recruit microtubule motors (Radtke et al. 2010), to move along microtubules in vitro (Wolfstein et al. 2006), dock to NPCs (Ojala et al. 2010; Anderson et al. 2014), and to release their genomes (Ojala et al. 2000). Thus, although the mass spectrometry analysis revealed only a few clear changes in the protein composition of V[1.0] capsids, V[0.5] capsids, and V[0.1] capsids, the functional assays suggest that the conformation of the HSV-1 proteins exposed on the capsid surfaces differ.</p><p>Based on these other studies, we therefore hypothesize that the differences in macrophage proteins associating with V[0.1] versus V[0.5] versus V[1] capsids were due to protein denaturation rather than protein extraction or removal from the capsids by increasing the KCl concentration from 0.1 to 0.5 to 1 M.</p><disp-quote content-type="editor-comment"><p>Lines 292-293. The text describing the similarities and differences in proteins binding to the various capsid preparations does not fit well with the data in Figure 8. For example, V[0.1] capsids do not really contain substantially more pUL41, especially compared to V[1] capsids; V[0.1] capsids contain similar amounts of pUL40 as V[1] capsid, but much more than V[0.5] capsids; etc. Perhaps the author could focus on differences that are statistically different. These data do not identify any major proteins that show a gradient from low in D capsids to higher in [0.5] to highest in [0.1] capsids that would fit with the gradient of effects shown in Figure 7F. The discussion of these results should reflect the limitation of these results.</p></disp-quote><p>We agree with the reviewer that we detected very few overall differences in the protein composition of V[0.5] when compared to V[1] capsids. The D capsids were most different from the 3 other capsid types. Furthermore, the major differences of V[0.1] versus V[0.5/1] capsids were in pUS3, VP13/14 and pUL16.</p><p>We therefore hypothesize that the differences in macrophage proteins associating with V[0.5] versus V[1] capsids were due to protein denaturation rather than protein extraction or removal from the capsids by increasing the KCl concentration from 0.5 to 1 M.</p><p>We have therefore modified lines 290-291 of the Results section:</p><p>“In contrast, V<sub>0.1</sub> capsids contained more tegument proteins, e.g. pUS3, VP13/14 and pUL16. All capsid preparations contained traces of membrane proteins and nuclear HSV-1 proteins contributing to DNA replication and packaging (Figure S8).”</p><p>Furthermore, we expanded lines 312-314 (now lines 309-320) of the discussion:</p><p>“While our MS analyses showed that V<sub>0.5</sub> and V<sub>1</sub> capsids recruited unique but also common proteins, the proteomes of V<sub>0.1</sub> and D capsids were more distinct. These specific interactions are consistent with the notion that a treatment with 0.5 or 1 M KCl during the detergent lysis of virions destabilized intra-tegument interactions that influenced, for example, the recruitment of dynactin, kinesin-1 and kinesin-2 from brain cytosol (Ojala et al., 2000; Radtke et al., 2010; Wolfstein et al., 2006).</p><p>Moreover, these results are consistent with immunoelectron microscopy data showing that the surface of distinct V capsid types display different tegument epitopes (Radtke <italic>et al.</italic>, 2010), and with cryoelectron tomography data revealing diminishing tegument densities from V<sub>0.1</sub>, V<sub>0.5</sub>, V<sub>1</sub> capsids to C capsids (Anderson <italic>et al.</italic>, 2014). Thus, the surface features of V<sub>0.1</sub>, V<sub>0.5</sub> and V<sub>1</sub> capsids differ as indicated by cryoelectron tomography, binding of anti-tegument antibodies, and the recruitment of distinct sets of cytosolic proteins from brain tissue (Radtke <italic>et al.</italic>, 2010), or macrophages as shown here.”</p></body></sub-article></article>